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Abstract  
The so-called X-linked inhibitor of apoptosis protein (XIAP) is the most intensively studied 
member of the inhibitor of apoptosis proteins (IAPs) and is the only cellular protein that 
directly binds to and inhibits caspases thereby blocking apoptosis. XIAP is frequently 
overexpressed in malignant cells and has therefore been investigated as a promising 
therapeutic target in cancer. 
Recently, IAPs have also been shown to influence pathways that modulate immune signalling 
via activation of NF-κB. One such pathway is the NOD signalling cascade that is responsible 
for the detection and defence against intracellular bacteria. XIAP has previously been shown 
to be an essential component of the NOD signalling cascade required for the activation of 
NF-κB mediated inflammatory responses. 
In order to study the role of XIAP in NOD signalling in response to bacterial infection, we 
used Shigella flexneri as a physiological stimulus for the NOD signalling cascade. Our data 
demonstrate that XIAP is essential for NF-κB activation after S. flexneri infection, but 
S. flexneri is able to efficiently down-regulate the XIAP-mediated inflammatory response. 
In particular, we show that S. flexneri infection co-opts the host protease calpain to cleave 
the BCL2 protein BID. Calpain-cleaved BID then translocates to the mitochondria where it 
mediates the selective release of the XIAP-antagonists SMAC and OMI from the 
mitochondrial intermembrane space. In the cytosol, SMAC and OMI inhibit XIAP and 
therefore interrupt the NOD-mediated inflammatory response. Critically, calpain-cleaved BID 
induces the release of SMAC and OMI, but not of Cyt c from the mitochondria. This selective 
permeability differentiates this process from the mitochondrial permeabilisation induced by 
apoptotic stimuli and permits the infected host cell not only to survive but also ensures 
bacterial propagation. 
The physiological importance of XIAP in controlling bacterial infection was confirmed in vivo 
in XIAP whole-body and liver-specific knockout mice, which show more bacterially induced 
necrotic liver lesions in response to S. flexneri infection than wildtype littermates. In contrast, 
SMAC/OMI and BID knockout mice, with unopposed XIAP activity, survived S. flexneri 
infection for much longer than wild type animals. 
Our findings demonstrate how the non-apoptotic antagonisation of XIAP by mitochondrial 
SMAC and OMI can control the delicate interaction between intracellular microbial pathogens 
and their hosts. 
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Zusammenfassung 
Das sogenannte X-linked inhibitor of apoptosis protein (XIAP) zählt zu den am besten 
untersuchten Mitgliedern der Familie der Inhibitoren der Apoptose (kurz IAPs). Bislang ist es 
das einzig bekannte Protein, das in der Lage ist, Caspasen direkt zu binden und zu 
inhibieren und somit Apoptose zu blockieren. XIAP wird in malignen Zellen häufig 
überexprimiert und stellt daher ein attraktives therapeutisches Ziel in der Krebstherapie dar.  
In den letzten Jahren wurden IAPs zudem als Bestandteil von immunregulatorischen 
Signalwegen identifiziert, die meist die Aktivierung von NF-κB beinhalten. In der NOD-
Signalkaskade, die für die Erkennung und Abwehr von intrazellulären Bakterien 
verantwortlich ist, wurde XIAP als entscheidender Faktor für die Aktivierung von NF-κB 
identifiziert.  
Um die Funktion von XIAP im Laufe einer bakteriellen Infektion zu untersuchen, wurde das 
Bakterium Shigella flexneri als physiologischer Stimulus der NOD Signalkaskade eingesetzt. 
Unsere Untersuchungen zeigen, dass S. flexneri in der Lage ist, die XIAP-vermittelte NOD-
Aktivierung zu unterdrücken. Insbesondere wurde gezeigt, dass S. flexneri die selektive 
Freisetzung der XIAP-Antagonisten SMAC und OMI aus dem mitochondrialen 
Intermembranraum induziert und somit XIAP inhibiert. S. flexneri vermittelt die Freisetzung 
von SMAC und OMI durch die Protease Calpain, die eine proteolytische Spaltung von BID 
katalysiert. Das gespaltene BID-Fragment transloziert an die Mitochondrien und induziert dort 
die Freisetzung von SMAC und OMI in das Cytosol. BID, prozessiert durch Calpain, 
permeabilisiert die Mitochondrien zwar für SMAC und OMI, jedoch ohne dabei auch 
Cytochrom c freizusetzen und gewährleistet somit das Überleben der infizierten Wirtszelle, 
um ungehinderte Vermehrung der Bakterien zu ermöglichen. 
Die Bedeutung von XIAP in der Kontrolle bakterieller Infektion konnte in „XIAP knockout“ 
Mäusen bestätigt werden. Ganzkörper XIAP knockout- sowie leberspezifische XIAP-
knockout Mäuse weisen deutlich mehr bakteriell-induzierte nekrotische Areale in der Leber 
auf, im Vergleich zu Wildtyp Mäusen. Im Gegensatz dazu überlebten SMAC/OMI und BID 
knockout Mäuse - mit ungehemmter XIAP Funktion - die S. flexneri Infektion deutlich länger 
als die Wildtyp Kontrollen. Grund hierfür ist die uneingeschränkte Funktion von XIAP, die eine 
bessere Bekämpfung der Infektion ermöglicht.   
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Zusammenfassend zeigt die vorliegende Arbeit, wie nicht-apoptotische Antagonisierung von 
XIAP durch mitochondriales SMAC und OMI die delikate Interaktion zwischen intrazellulären 
Bakterien und ihren Wirten beeinflusst.  
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Introduction 
Inhibitor of Apoptosis Proteins ( IAPs) - regulators of cel l  death  
The inhibitor of apoptosis proteins (IAPs) were originally identified in baculoviruses when 
homologs for p35, a protein that prevents apoptosis after viral infection, were investigated. 
The viral CpGV gene product was found to functionally complement p35 in preventing 
apoptosis, caused by the Autographa californica nuclear polyhedrosis virus, which was thus 
called the inhibitor of apoptosis (Crook et al., 1993). One year later Clem and Miller 
demonstrated that IAP homologs block apoptosis independently of viral infection, indicating 
that IAPs interact directly with the cellular apoptotic machinery (Clem and Miller, 1994). In the 
following years, IAPs were found to be an evolutionary conserved protein family in various 
eukaryotic species including yeast, fly and mammals (Deveraux and Reed, 1999). Their 
defining feature is the presence of one or several zinc-finger motifs, known as baculoviral IAP 
repeat (BIR) domains (Birnbaum et al., 1994), some of which are required for their function to 
inhibit caspases - the main executioners of apoptosis, which is a form of programmed cell 
death. 
The human genome encodes eight different IAPs, but in spite of their name as inhibitor of 
apoptosis, several members of the family are known to have distinct functions that are 
unrelated to apoptosis. Cellular processes such as cell cycle regulation, protein degradation 
and other signal transduction cascades are also subject to regulation by IAPs (Salvesen and 
Duckett, 2002). Nevertheless, the cellular IAPs (cIAP1 and cIAP2) efficiently impede 
apoptosis, triggered by multiple stimuli, when introduced into mammalian cells (Deveraux 
and Reed, 1999). However, cIAPs are weak caspase inhibitors, presumably lacking structural 
features present in other IAPs. Therefore they represent protein scaffolds suitable for direct 
caspase inhibition but have lost or never acquired specific caspase inhibitory interaction sites 
(Eckelman and Salvesen, 2006). Currently, they are widely recognised for their regulatory 
function in the TNF-receptor pathway (Vandenabeele and Bertrand, 2012). 
The X-linked inhibitor of apoptosis protein (XIAP, encoded by BIRC4) is the best-studied IAP 
and the only family member that can directly bind to and inhibit caspases, thereby blocking 
apoptosis (Deveraux et al., 1997) (Figure 1).  
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Figure 1. Domain structure of XIAP. XIAP comprises three BIR domains, each exerting different 
functions, a ubiquitin-associated (UBA) domain, which allows binding to poly-ubiquitin (Ub) chains and 
a RING finger domain, which is responsible for dimerisation and E3-ligase function. (modified from 
Gyrd-Hansen and Meier, 2010) 
 
On the one hand, the BIR3 domain of XIAP can bind to the dimerisation surface of caspase-
9, maintaining it in an inactive monomeric form. On the other hand, the linker region between 
the BIR1 and BIR2 domains binds to caspase-3 or -7 and blocks their activity by steric 
occlusion of caspase-substrates (Salvesen and Duckett, 2002). The BIR1 domain itself is not 
involved in caspase inactivation and interacts with a different set of proteins, implicating XIAP 
in other cellular functions, which will be described below.  
Based on their ability to inhibit apoptosis and the frequently elevated expression of IAPs in 
tumour cells, IAPs have been mainly studied in mammalian cancer. Specifically, elevated 
expression of XIAP is often found in malignant cells and is thought to be responsible for 
resistance to anti-cancer therapeutics (Schimmer et al., 2006; Tamm et al., 2004a, 2004b; 
Mizutani et al., 2007). Congruently, ectopic overexpression of XIAP in tumour cell lines 
confers resistance to apoptosis (Deveraux et al., 1997) and vice versa XIAP-targeting by its 
specific knock-down sensitises tumour cells to apoptosis (Kashkar et al., 2007).  
Nevertheless, XIAP-targeting has thus far failed to completely restore the apoptotic 
machinery under physiological conditions. Furthermore, studies assessing the prognostic 
importance of XIAP in tumour patients or its predictive role for chemotherapy have been 
inconsistent between different malignancies (reviewed in Kashkar, 2010). Additional factors 
such as a defective mitochondrial apoptotic pathway might be responsible for this 
discrepancy. 
 
The cel lular apoptotic machinery 
The regulation of tissue homeostasis is critical for all multicellular organisms. The number of 
cells is tightly controlled by apoptosis - a form of programmed cell death (Kerr et al., 1972). 
Apoptosis ultimately involves the activation of caspases, members of a highly conserved 
binding to 
TAB1
binding to 
caspase 3, 7
SMAC / OMI
binding to 
caspase 9
binding to 
Poly Ub 
chains
dimerisation
E3 ligase
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family of cystein proteases, which are responsible for the majority of proteolytic events that 
result in the destruction of the cell (Fuentes-Prior and Salvesen, 2004). Caspases can be 
activated through two major pathways: the “extrinsic” and the “intrinsic” (also called 
mitochondrial) pathway of apoptosis.  
The extrinsic pathway of apoptosis can be initiated externally by ligands of the TNF-receptor 
family (e.g. TNF, FAS-ligand) that induce receptor oligomerisation and recruitment of the 
adaptor molecule FAS-associated death domain protein (FADD) to form the death inducing 
signalling complex (DISC) together with pro-caspase-8. Activated caspase-8 can then 
directly cleave and activate executioner caspases 3 and 7. 
The intrinsic or “mitochondrial pathway of apoptosis” can be initiated autonomously by the 
cell and is caused by overwhelming cellular stress such as DNA damage, extensive protein 
aggregation or growth factor withdrawal (Strasser et al., 2000). The mitochondrial pathway of 
apoptosis is characterised by mitochondrial outer membrane permeabilisation (MOMP), 
which results in the release of Cytochrome c (Cyt c) from the mitochondrial intermembrane 
space (IMS). The release of Cyt c into the cytosol promotes the ATP-dependent formation of 
the apoptosome complex – comprising of Cyt c, apoptotic protease-activating factor 1 
(APAF-1) and pro-caspase-9 - which catalyses auto-activation of the initiator caspase-9 (Li et 
al., 1997; Zou et al., 1999) followed by activation of executioner caspases.  
In addition, both pathways of apoptosis can intersect. Beside direct activation of executioner 
caspases, caspase-8-dependent cleavage of the BH3-only protein BID allows amplification 
of the caspase cascade to ensure efficient cell demolition (Kaufmann et al., 2012). The 
caspase-8-cleaved C-terminal fragment of BID (tBID) translocates to the mitochondria and 
leads to MOMP, followed by the release of Cyt c and downstream caspase activation. 
Nevertheless this step is not critical to all cell types, which are accordingly categorised into 
type I (BID-independent) and type II (BID-dependent) cells. Experiments with diverse cell 
types from BID-deficient mice have revealed an important role for BID in Fas-induced 
apoptosis in type II cells, which include hepatocytes and pancreatic β-cells (Yin et al., 1999; 
McKenzie et al., 2008). Of note, while BID knockout mice are resistant to Fas-ligand-induced 
hepatocyte apoptosis, additional loss of XIAP can rescue this effect. Accordingly, XIAP is one 
important discriminator between type I and type II Fas-induced apoptosis (Jost et al., 2009). 
But whether a cell behaves like type I or type II does not depend on a single determinant, but 
on the ratio between processed effector caspases, DISC formation, caspase-8 activation 
and on the levels of free XIAP, respectively (Kaufmann et al., 2012).  
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Apoptosis is a tightly regulated process and its dysregulation culminates in multiple human 
diseases. Whereas the failure to execute apoptosis in regenerating tissues contributes to 
cancer, excessive apoptosis in post-mitotic tissues can cause degenerative disorders. 
Caspases – the executioner of both apoptotic pathways - are subject to inhibition by the 
IAPs. IAPs therefore confer protection from death-inducing stimuli, providing an important 
level of control of the apoptotic pathway. 
 
Regulators of mitochondrial outer membrane permeabi l isat ion – 
the BCL2 proteins  
IAP antagonisation is dependent on the liberation of mitochondrial IAP-binding motif (IBM)-
containing proteins by MOMP. MOMP is often regarded as a point of no return and therefore 
must be tightly regulated. Members of the B-cell lymphoma 2 (BCL2) family are crucial 
regulators of MOMP. The pro-apoptotic BCL2 members can sense cellular damage and 
directly induce MOMP by forming pores in the outer mitochondrial membrane (OMM) in 
contrast to the anti-apoptotic members that can block this event. The precise regulation of 
MOMP therefore depends on the fine-tuned interactions among pro- and anti-apoptotic 
BCL2 family members.  
The common structural feature shared by the members of this protein family is the BCL2 
homology (BH) domain. Functionally, BCL2 family proteins can be divided into three groups: 
i) anti-apoptotic members, ii) pro-apoptotic effectors and iii) pro-apoptotic BH3 only proteins 
(Cory and Adams, 2002) (Figure 2). 
Ant i-apoptot ic BCL2 proteins 
  BCL2, BCL-W, BCL-XL, A1, MCL-1 
 
Pro-apoptot ic BCL2 proteins 
     Effectors 
     BAK, BAX, BOK 
      
BH3-only proteins 
 BID, BIM, BAD, BIK, BMF, BNIP3, HRK, 
NOXA, PUMA 
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Patch clamping
An electrophysiological 
technique used for measuring 
ion channel activity over 
membranes. Typically, a small 
diameter (1μm) micropipette 
serves as the electrode and is 
applied to a small area of 
membrane (the ‘patch’), 
allowing the activity of one  
or a few ion channels to be 
measured.
Micelle
An aggregate (typically 
spherical) of varying size 
comprised of lipids. In aqueous 
environments, the hydrophobic 
lipid tails orientate to the 
centre of the micelle and the 
hydrophilic head groups are  
on the surface.
analysis of BAX-permeabilized liposomes revealed 
openings of varying size (25–100 nm) that appeared 
concurrently with permeabilization in a manner that 
was BCL-XL inhibitable49. The diameter of these open-
ings is consistent with the ability of BAX to induce the 
size-independent release of dextrans. Supporting a lipidic 
pore model, the edges of these BAX-induced pores are 
smooth and devoid of proteinaceous material. In contrast, 
protein pores formed by the toxin pneumolysin, as ana-
lysed by cryo-EM, are uniform in nature and decorated 
around the edges with toxin molecules50. However, similar 
pore-like structures have yet to be found on mitochondria 
during MOMP.
Post-MOMP regulation of IMS proteins
Although MOMP itself provides little specificity as to 
which IMS proteins are released, studies suggest that 
release of different IMS proteins can be selective. This may 
be through the regulation of IMS protein inter action with 
mitochondrial membranes or by mitochondrial inner 
membrane remodelling.
IMS protein membrane attachment. Apoptosis induc-
ing factor (AIF) is an IMS protein that is anchored on 
the mitochondrial inner membrane and displays much 
slower release kinetics than cytochrome c following 
MOMP31. This protracted release may be owing to the 
requirement for AIF cleavage post-MOMP by cytosolic 
proteases to liberate AIF from the mitochondrial inner 
membrane. One candidate protease is cytosolic calpain I, 
which can cleave AIF in vitro to promote its release from 
permeabilized mitochondria51.
Electrostatic interactions between cytochrome c and 
the mitochondrial lipid cardiolipin have been proposed 
to regulate its release52. However, it might be expected that 
the ionic strength of the cytosol should suffice to disrupt 
these interactions53.
Post-MOMP mitochondrial inner membrane remodelling. 
Other mechanisms may control IMS protein release fol-
lowing MOMP. Mitochondrial cristae are involutions 
of the mitochondrial inner membrane that greatly increase 
the mitochondrial surface area available for oxidative 
phosphorylation and ATP synthesis. Cristae are dynamic 
structures and their accessibility to the IMS is largely 
dictated through regulation of cristae junction size. As 
most cytochrome c resides in mitochondrial cristae, sev-
eral studies have addressed whether cristae remodelling 
provides an additional means of regulating cytochrome c 
release following MOMP. Various BH3-only proteins, 
including BID, BIM, BNIP3 (BCL-2 and adenovirus 
E1B 19 kDa protein-interacting protein 3) and BCL-2-
interacting killer (BIK) have been found to promote 
mitochondrial cristae remodelling54–57. Treatment of 
mitochondria in vitro with the BH3 protein tBID induced 
dramatic inner membrane remodelling, leading to inter-
connected cristae with widened junctions and cyto-
chrome c mobilization into the IMS55. Two IMS proteins, 
optic atrophy protein 1 (OPA1; a dynamin-like GTPase) 
and presenilins-associated rhomboid-like protein (PARL; 
a rhomboid protease) have been found to regulate cristae 
remodelling during apoptosis58,59. Following MOMP, dis-
assembly of OPA1 hetero-oligomers is required for the 
widening of cristae junctions, whereas PARL cleavage of 
OPA1 generates an OPA1 cleavage product that maintains 
tight cristae junctions that prevent cytochrome c release. 
Functionally, PARL loss renders cells more susceptible 
to apoptosis induced by intrinsic stimuli, whereas OPA1 
overexpression is protective58,59.
Although cristae remodelling requires activated BAX 
or BAK, it can occur in the absence of MOMP because 
pharmacological inhibitors of MOMP still allow remod-
elling to occur54. Remodelling was associated with the 
mobilization of cytochrome c to the IMS and, like pre vious 
studies, disassembly of OPA1 was required for remodel-
ling to occur. In this study, however, gross changes in 
mitochondrial morphology were not apparent. Instead, 
a subtle narrowing, rather than widening, of cristae junc-
tions occurred. Similarly, correlative light microscopy and 
EM of apoptotic cells revealed that gross alterations in 
mitochondrial structure were detected only after MOMP 
and caspase activation had occurred, arguing against a 
causal role for large mitochondrial structural changes 
Box 3 | Regulation of MOMP by the BCL-2 family
The B cell lymphoma 2 (BCL-2) family of proteins is divided into three groups based on 
their BCL-2 homology (BH) domain organization (see the figure, part a). Pro-apoptotic 
BCL-2 proteins can be sub-divided into effectors (the proteins that actually cause 
mitochondrial outer membrane permeabilization (MOMP)) or BH3 only (the proteins that 
relay the apoptotic signal to the effectors). Although BCL-2-related ovarian killer protein 
(BOK) displays similar domain architecture to BCL-2-associated X protein (BAX) and BCL-2 
antagonist or killer (BAK), there is little evidence that it is a functional effector. Two 
prominent models of BAX and BAK activation have been proposed, termed the indirect 
activator (or neutralization) and direct activator–derepressor models of activation150,151 
(see the figure, part b). The indirect activator model asserts that BAX and BAK are bound  
in a constitutively active state by anti-apoptotic BCL-2 proteins and that competitive 
interactions of BH3-only proteins with anti-apoptotic BCL-2 family members is sufficient 
to release activated BAX and BAK. In the direct activator–derepressor model, BAX and 
BAK are activated following interaction with a subset of BH3-only proteins known as direct 
activators, and anti-apoptotic BCL-2 proteins prevent MOMP either by sequestering the 
activating BH3-only proteins or by inhibiting activated BAX and BAK. A second subset  
of BH3-only proteins, termed sensitizers, cannot directly activate BAX and BAK but 
neutralize anti-apoptotic BCL-2 proteins. Definitive proof for either model has proved 
challenging; it is likely that aspects of both models are correct. BAD, BCL-2 antagonist of 
cell death; BID, BH3-interacting domain death agonist; BIK, BCL-2-interacting killer; BIM, 
BCL-2-interacting mediator of cell death; BMF, BCL-2-modifying factor; BNIP3, BCL-2 and 
adenovirus E1B 19 kDa protein-interacting protein 3; HRK, harakiri; PUMA, p53 
upregulated modulator of apoptosis; TM, transmembrane.
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IMS protein membrane attachment. Apoptosis induc-
ing factor (AIF) is an IMS protein that is anchored on 
the mitochondrial inner membrane and displays much 
slower release kinetics than cytochrome c following 
MOMP31. This protracted release may be owing to the 
requirement for AIF cleavage post-MOMP by cytosolic 
proteases to liberate AIF from the mitochondrial inner 
membrane. One candidate protease is cytosolic calpain I, 
which can cleave AIF in vitro to promote its release from 
permeabilized mitochondria51.
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release following MOMP. Various BH3-only proteins, 
including BID, BIM, BNIP3 (BCL-2 and adenovirus 
E1B 19 kDa protein-interacting protein 3) and BCL-2-
interacting killer (BIK) have been found to promote 
mitochondrial cristae remodelling54–57. Treatment of 
mitochondria in vitro with the BH3 protein tBID induced 
dramatic inner membrane remodelling, leading to inter-
connected cristae with widened junctions and cyto-
chrome c mobilization into the IMS55. Two IMS proteins, 
optic atrophy protein 1 (OPA1; a dynamin-like GTPase) 
and presenilins-associated rhomboid-like protein (PARL; 
a rhomboid protease) have been found to regulate cristae 
remodelling during apoptosis58,59. Following MOMP, dis-
assembly of OPA1 hetero-oligomers is required for the 
widening of cristae junctions, whereas PARL cleavage of 
OPA1 generates an OPA1 cleavage product that maintains 
tight cristae junctions that prevent cytochro e c release. 
Functionally, PARL loss rende s cells more susc ptible 
to apoptosis induced by intrinsic stimuli, whereas OPA1 
overexpression is protective58,59.
Although cristae remodelling requires activated BAX 
or BAK, it an oc ur in the absence of MOMP because 
pharmacol gi al inhibitors of MOMP still allow r mod-
elling to occur54. Remodelling was associated with th  
mobilization of cytochrome c to the IMS and, like pre vious 
studies, disassembly of OPA1 was required for remodel-
ling to occur. In this study, however, gross changes in 
mitochondrial morphology were not apparent. Instead, 
a subtle narrowing, rather than widening, of cristae junc-
tions occurred. Similarly, correlative light microscopy and 
EM of apoptotic cells revealed that gross alterations in 
mitochondrial structure were detected only after MOMP 
and caspase activation had occurred, arguing against a 
causal role for large mitochondrial structural changes 
Box 3 | Regulation of MOMP by the BCL-2 family
The B cell lymphoma 2 (BCL-2) family of proteins is divided into three groups based on 
their BCL-2 homology (BH) domain organization (see the figure, part a). Pro-apoptotic 
BCL-2 proteins can be sub-divid d into effectors (the proteins that actually cause 
mitochondrial outer membr ne perm abilization (MOMP)) or BH3 only ( he proteins that 
relay the ap ptotic signal to the effec ors). Althoug  BCL-2-related ovarian killer protein 
(BOK) displays similar domai  architecture o BCL-2-associated X protein (BAX) and BCL-2 
n agonist or killer (BAK), there is little evidence that it is a functional effector. Two 
promin nt models of BAX and BAK activation have been p oposed, termed the indirect 
activator (or neutralization) nd direct activat r–derepressor models of activation150,151 
(se  the figure, part b). The indirect activator model asserts that BAX and BAK are bound  
in a constitutively active state by anti-apoptotic BCL-2 proteins and that competitive 
interactions of BH3-only proteins with anti-apoptotic BCL-2 family members is sufficient 
to release activated BAX and BAK. In the direct activator–derepressor model, BAX and 
BAK are activated following interaction with a subset of BH3-only proteins known as direct 
activators, and anti-apoptotic BCL-2 proteins prevent MOMP either by sequestering the 
activating BH3-only proteins or by inhibiting activated BAX and BAK. A second subset  
of BH3-only proteins, termed sensitizers, cannot directly activate BAX and BAK but 
neutralize anti-apoptotic BCL-2 proteins. Definitive proof for either model has proved 
challenging; it is likely that aspects of both models are correct. BAD, BCL-2 antagonist of 
cell death; BID, BH3-interacting domain death agonist; BIK, BCL-2-interacting killer; BIM, 
BCL-2-interacting mediator of cell death; BMF, BCL-2-modifying factor; BNIP3, BCL-2 and 
adenovirus E1B 19 kDa protein-interacting protein 3; HRK, harakiri; PUMA, p53 
upregulated modulator of apoptosis; TM, transmembrane.
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analysis of BAX-permeabilized liposomes revealed 
openings of varying size (25–100 nm) that appeared 
concurrently with permeabilization in a manner that 
was BCL-XL inhibitable49. The diameter of these open-
ings is consistent with the ability of BAX to induce the 
size-independent release of dextrans. Supporting a lipidic 
pore m del, the dges thes  BAX-induced pores are
smo th a d evoid of proteinaceous material. In contras , 
protein pores formed by the toxin pneumolysin, as ana-
lysed by cryo-EM, are uniform in nature and decorated 
around the edges with toxin molecules50. However, similar 
pore-like structures have yet to be found on mitochondria 
during MOMP.
Post-MOMP regulation of IMS proteins
Although MOMP itself provides little specificity as to 
which IMS proteins are rel ased, tudies sugge t that 
release of di ferent IMS proteins ca  be selective. This may 
be through the regulation of IMS protein inter action with 
mitochondrial membranes or by mitochondrial inner 
membrane remodelling.
IMS protein m mbrane attachment. Apopt sis induc-
ing factor (AIF) is an IMS protein that is nchored on 
the mitochondrial inner membrane and displays much 
slower release kinetics than cytochrome c following 
MOMP31. This protracted release m y be owing to the 
requirement for AIF cleavage post-MOMP by cytosolic 
proteases to liberate AIF from the mitochondrial inner 
membrane. One candidate protease is cytosolic calpain I, 
which can cleave AIF in vitro to promote its release from 
permeabilized mitochondria51.
Electrostatic interactions between cytochrome c and 
the mitochondrial lipid cardiolipin have been proposed 
to regulate its release52. However, it might be expected that 
the ionic strength of the cytosol should suffice to disrupt 
these in eractions53.
Post-MOMP mitoc drial inner membrane remodelling. 
Other mechanisms may control IMS protein release fol-
lowing MOMP. Mitochondrial cristae are involutions 
of the mitochondrial inner membrane that greatly increase 
the mitochondrial surface area available for oxidative 
phosphorylation and ATP synthesis. Cristae are dynamic 
structures and their accessibility to the IMS is largely 
dictated through regulation of cristae junction size. As 
most cytochrome c resides in mitochondrial cristae, sev-
eral studies have addressed whether cristae remodelling 
provides an additional means of regula i  cyt chrome c 
release following MOMP. Various BH3-only proteins, 
including BI , BIM, BNIP3 (BCL-2 and adenovirus 
E1B 19 kDa protein-interacting protein 3) and BCL-2-
interacting killer (BIK) have been found to promote 
mitoch ndrial cristae emodelling54–57. Tr atment of 
mitochondria i  vitro with the BH3 prot in tBID induced 
dramatic inner membrane remodelling, leading to inter-
connected cristae with widened junctions and cyto-
chrome c mobilizatio  into the IMS55. Two IMS proteins, 
optic atrophy pr tein 1 (OPA1; a dynamin-like GTPase) 
and presenilins-associated rhomboid-like protein (PARL; 
a rhomboid protease) have been found to regulate cristae 
remodelling during apoptosis58,59. Following MOMP, dis-
assembly of OPA1 hetero-oligomers is required for the 
widening of cristae junctions, whereas PARL cleavage of 
OPA1 generates an OPA1 cleavage product that maintains 
tight cristae junctions that prevent cytochrome c release. 
Functionally, PARL loss renders cells more susceptible 
to ap ptosis induce  by intrinsic stimuli, whereas OPA1 
overexp ssion is protectiv 58,59.
Alth ugh cristae remodelling requires activated BAX 
or BAK, it can occur in the absence of P because 
pharmacological inhibitors of MOMP still allow remod-
elling to occur54. Remodelling was associated with the 
mobilization of cytochrome c to the IMS and, like pre vious 
studies, disassembly of OPA1 was required for remodel-
ling to occur. In this study, however, gross changes in 
mitochondrial morphology were not apparent. Instead, 
a subtle narrowing, rather than widening, of cristae junc-
tions occurred. Similarly, correlative light m croscopy and 
EM of apoptotic cells revealed that gross alterations in 
mitochondrial structure were detected only after MOMP 
and caspase activation had occurred, arguing against a 
causal role for large mit chon rial st uctural changes 
Box 3 | Regulation of MOMP by the BCL-2 family
The B cell lymph ma 2 (BCL-2) family of pr t ins is divided into thr e groups based on 
their BCL-2 homology (BH) domain organization (see the figure, part a). P -apo t ic 
BCL-2 proteins can be sub-divid d into eff ctors (the proteins that actually c use 
mitochondrial outer membrane permeabilization (MOMP)) or BH3 only (the proteins that 
relay the apoptotic signal to the effectors). Although BCL-2-related ovarian killer protein 
(BOK) displays similar domain architecture to BCL-2-associated X protein (BAX) and BCL-2 
antagonist or killer (BAK), there is little evidence that it is a functional effector. Two 
prominent models of BAX and BAK activation have been proposed, termed the indirect 
activator (or neutralization) and direct activator–derepressor models of activation150,151 
(see the figure, part b). The indirect activator model asserts that BAX and BAK are bound  
in a constitutively active state by anti-apoptotic BCL-2 proteins and that competitive 
interactions of BH3-only proteins with anti-apoptotic BCL-2 family members i  sufficient 
to release activated BAX and BAK. In the direct activator– erepressor model, BAX and 
BAK are activated following interaction with a subset of BH3-only proteins known as direct 
tiv tors, and anti-a optotic BCL-2 proteins prevent MOMP either by sequ stering the 
activating BH3-only proteins or by inhibiting activated BAX nd BAK.  second subset  
of BH3-only proteins, ermed sensitizers, cannot directly activate BAX and BAK but 
neutralize anti-apoptotic BCL-2 proteins. Definitive proof fo  ither model has proved 
challenging; it is likely that aspects f both models are correct. AD, BCL-2 antagonist of 
cell death; BID, BH3-interacting domain death agonist; BIK, BCL-2-interacting killer; BIM, 
BCL-2-interacting mediator of cell death; BMF, BCL-2-modifying factor; BNIP3, BCL-2 and 
adenovirus E1B 19 kDa protein-interacting protein 3; HRK, harakiri; PUMA, p53 
upregulated modulator of apoptosis; TM, transmembrane.
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Figure 2. The BCL2 protein family. The BCL2 protein family comprises three subgroups based 
on their different domain structure. Anti-apoptotic members contain four conserved BH domains and 
one transmembrane (TM) domain. Pro-apoptotic members can be further subdivided into effectors 
(multi-domain proteins that cause MOMP) with three BH domains and a TM domain, while BH3-only 
proteins (regulators of the effectors) contain only one BH domain (modified from Tait and Green, 
2010). 
 
Anti-apoptotic BCL2 proteins, such as BCL2 itself or BCL-XL are not exclusively expressed 
on the OMM, but also on other cellular membranes. Nevertheless, their function has mostly 
been studied in the context of mitochondria where they potently inhibit apoptosis induced by 
cytotoxic stress. With a hydrophobic groove on their surface, anti-apoptotic BCL2 proteins 
can bind to pro-apoptotic family members and thus retain them in an inactive state (Sattler et 
al., 1997). 
BAX and BAK are members of the pro-apoptotic BCL2 family and indispensable for MOMP. 
While individual null mutations of BAX or BAK in mice have no altered apoptotic response, 
BAX/BAK double null mutants show dramatically impaired apoptosis during development 
(Lindsten et al., 2000). Whereas BAK resides on the OMM where it is bound to anti-
apoptotic MCL1 and BCL-XL (Willis et al., 2005), BAX is a soluble cytosolic monomer that 
undergoes conformational change upon apoptotic stimuli followed by translocation to the 
OMM. Once in the OMM the exposed BH3 domain of BAX binds to a hydrophobic groove of 
another active BAX molecule, allowing homo-oligomerisation (Dewson and Kluck, 2009). The 
currently held view is that during MOMP, BAX and/or BAK oligomers form pores in the OMM, 
that facilitate the release of Cyt c, SMAC, OMI and other soluble proteins from the IMS 
through a mitochondrial pore (Munoz-Pinedo et al., 2006; Youle and Strasser, 2008). 
However, despite decades of intensive research, the exact biochemical nature of pore 
formation (i.e. the number of BAX/BAK molecules required; further interaction partners) 
remains controversial and different models have been proposed (reviewed in Tait and Green, 
2010).  
The third group of BCL2 proteins, known as the “BH3-only proteins” consists of a large and 
diverse collection of proteins whose only common feature is the conserved BH3-domain 
(e.g. BID, BAD, NOXA, PUMA). They are sentinels for cellular damage and promote 
apoptosis either by neutralising their anti-apoptotic relatives („sensitiser“) or by directly 
activating BAX and BAK („direct activators“) (Chipuk et al., 2010).  
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Regulat ion of IAPs by IBM-containing proteins  
Regulation of the IAPs is executed by the mitochondrial IBM-containing proteins that are 
released from the mitochondria following MOMP. All mammalian IBM-containing proteins 
that have been discovered so far, reside mainly in the IMS and need to undergo proteolytic 
processing to expose their IBM (Salvesen and Duckett, 2002). Second mitochondrial derived 
activator of caspases (SMAC) and OMI (also called HtrA2) are the most important IBM-
containing proteins involved in apoptosis (Verhagen et al., 2000; Martins et al., 2002). SMAC 
and OMI are synthesised as precursor proteins in the cytosol comprising an N-terminal 
mitochondrial targeting sequence (MTS) that is cleaved off following mitochondrial import, 
exposing the conserved N-terminal IBM of the mature protein (“AVPI” in the case of SMAC, 
“AVPS” in the case of OMI). When apoptosis is initiated and MOMP occurs, SMAC and OMI 
are, simultaneously with Cyt c, released into the cytosol to relieve caspases from IAP 
inhibition (Figure 3). 
 
F igure 3. Extr insic and intr insic (mitochondria l )  apoptot ic pathways. Apoptosis can be 
induced by stimulation of death receptors with their respective ligands (TNF, FAS, TRAIL). The death 
receptor oligomerises and induces formation of the DISC, which activates pro-caspase-8. Active 
initiator caspase-8 activates executioner caspase-3 followed by cleavage of apoptotic substrates. The 
mitochondrial apoptotic pathway is activated upon death stimuli that lead to oligomerisation of 
cytosolic BAX, which inserts into the OMM and induces MOMP. SMAC, OMI and Cyt c are released 
into the cytosol where the latter triggers the formation of the apoptosome (together with pro-caspase-
9 and APAF1), results in activation of initiator caspase-9. Caspase-9 can cleave and activate 
executioner caspase-3 leading to apoptotic cell death. Furthermore, SMAC and OMI antagonise XIAP, 
XIAP
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preventing it from inactivating caspases, thus supporting the execution step of apoptosis. Caspase-8 
can also activate the mitochondrial pathways of apoptosis by cleaving BID into a tBID fragment, which 
translocates to the mitochondria and activates BAX. 
 
Significant efforts to develop pharmacological IAP antagonists as anti-cancer drugs have 
been focussing on the synthesis of the purified IAP binding motif (IBM) – that is capable of 
inhibiting IAPs. In recent years, several novel types of these IAP antagonists, frequently 
referred to as “SMAC mimetics” have entered clinical trials (LaCasse et al., 2008). 
 
IAPs in inf lammatory signal l ing  
In addition to their well-known function in apoptosis, IAPs are increasingly being associated 
with diverse non-apoptotic pathways such as inflammation and innate immunity. A 
remarkably conserved RING finger domain equips some IAPs with E3-ligase function (Galbán 
and Duckett, 2010) and implicates them in ubiquitin-dependent signalling events that 
regulate the activation of the transcription factor nuclear factor κB (NF-κB) and mitogen 
activated protein (MAP) kinase pathways that drive the expression of genes involved in 
inflammation and cell survival (Gyrd-Hansen and Meier, 2010). 
Evidence for the involvement of IAPs in innate immunity first emerged in 2005, when 
Gesellchen and colleagues showed that the Drosophila IAP homologue DIAP2 is 
indispensable for NF-κB activation in response to Gram-negative bacterial infection 
(Gesellchen et al., 2005).  
XIAP, in particular, has been implicated in inflammatory signalling in response to intracellular 
bacterial infection. Specifically, XIAP knockout mice failed to clear bacterial infection with 
Listeria monocytogenes (Bauler et al., 2008) or Chlamydophila pneumonia (Prakash et al., 
2010). It is only recently that the molecular mechanisms of XIAP in immune signalling are 
beginning to be understood in more detail. XIAP - and especially its E3-ligase function - was 
reported to be important in the NOD signalling cascade (Krieg et al., 2009; Damgaard et al., 
2012). Nucleotide-binding oligomerisation domain (NOD) receptors are members of the 
nucleotide-binding domain and leucine-rich repeat (NLR) containing proteins that function as 
cytosolic pattern-recognition receptors and trigger inflammatory responses against 
intracellular bacteria through activation of NF-κB (Chamaillard et al., 2003). The NOD 
signalling pathway culminates in expression of pro-inflammatory cytokines and chemokines, 
necessary for a robust anti-microbial environment and proper activation of an immune 
response. In 2009, Krieg and colleagues proposed XIAP as a new and indispensable 
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component in the NOD signalling pathway in which XIAP was shown to interact with the 
receptor interacting protein kinase 2 (RIPK2) via its BIR2 domain (Krieg et al., 2009). 
According to this view, XIAP serves as a link between the NOD signalling complex (NOD, 
RIPK2, XIAP) and components of the IKK-activating complex, since an interaction between 
XIAP and TAB1, an upstream adaptor for activation of the kinase TAK1, has been described 
(Lu et al., 2007). TAK1 in turn phosphorylates the catalytic subunits of the IKK complex (IKKα 
and IKKβ) leading to phosphorylation and proteasomal degradation of IκBs (IκBα and IκBβ). 
After IκB degradation, NF-κB subunits can translocate to the nucleus and activate target 
genes involved in the inflammatory response. 
Further insight into the detailed molecular signalling pathway was recently provided by 
Damgaard and colleagues, who investigated the role of XIAP in NOD signalling. They provide 
evidence that XIAP ubiquitylates RIPK2 in response to NOD2 stimulation and thereby recruits 
the linear ubiquitin chain assembly complex (LUBAC) to the NOD signalling complex. LUBAC 
in turn serves as an ubiquitin ligase downstream of XIAP and is required for efficient 
activation of NF-κB and cytokine secretion (Damgaard et al., 2012) (Figure 4). Since NOD1 
and NOD2 differ only in ligand specificity and share the majority of their signalling pathway, 
this finding might be relevant for NOD1 activation and needs further investigation. 
 
Figure 4. Intracel lu lar NOD signal l ing cascade. Synthetic minimal peptidoglycan (PGN)  
fragments stimulate NOD, leading to complex formation with XIAP and RIPK2. Recruitment of TAB1 to 
poly-ubiquitylated RIPK2 activates TAK1, which in turn activates the IKK complex finally leading to 
proteasomal degradation of IκBα and liberation of the NF-κB subunits for nuclear translocation where 
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they induce expression of target genes, such as IL-8. LUBAC is recruited to polyubiquitylated RIPK2 
and stabilises interaction with NEMO.  
 
Shigel la f lexneri as a physiological st imulus of immune responses 
The Gram-negative enteropathogenic bacterium Shigella flexneri represents a well-
established model for intracellular infections. In patients, invasion and inflammatory 
destruction of the colonic epithelium by S. flexneri causes bacillary dysentery (Shigellosis) a 
severe form of bloody diarrhea, predominantly occurring in developing countries due to poor 
sanitary conditions.  
S. flexneri is known to stimulate an innate immune response through the activation of NOD1 
(Girardin et al., 2001, 2003) and is a well-suited model to analyse the complex host-
pathogen interactions that shape the immune response of intestinal epithelial cells. The 
pathogenesis of S. flexneri infection is closely linked to its ability to invade and replicate in the 
cytosol of epithelial cells thus avoiding exposure to the extracellular host immune defence 
(Philpott et al., 2000). In epithelial cells an inflammatory response is produced by activation of 
NF-κB, followed by production of cytokines such as IL-8, leading to recruitment of immune 
cells to contain the bacterial infection (Phalipon and Sansonetti, 2007) (Figure 5). 
 
 
F igure 5: Infect ion of the colonic epithel ium by S. f lexner i . Schematic model illustrating 
S. flexneri infection of the colonic epithelium. Multiplication of S. flexneri in epithelial cells leads to a 
severe form of inflammatory colitis (Shigellosis) (modified from Ashida et al., 2011). 
 
 
  INTRODUCTION 
                   
 
13 
Aim of the study  
In addition to its well-recognised function as an inhibitor of apoptosis, XIAP has recently been 
shown to play an important role in NOD signalling during innate immune responses (Gyrd-
Hansen and Meier, 2010). Specifically, NOD signalling in response to stimulation by minimal 
peptidic fragments induced an inflammatory response involving NF-κB activation and 
cytokine release that was dependent on XIAP (Krieg et al., 2009; Damgaard et al., 2012). 
However, minimal peptidic fragments are insufficient in mimicking the complex 
circumstances of a physiological infection and the relevance of these findings to physiological 
stimulation of the NOD-mediated immune responses against bacterial infection remained 
unresolved and is the subject of this thesis. As a natural antagonist of XIAP function, the 
mitochondrial intermembrane space protein SMAC is capable of disrupting XIAPs function as 
an inhibitor of apoptosis (Verhagen et al., 2000). On this basis we investigated whether XIAPs 
function in an innate immune response to bacterial infection by S. flexneri was similarly 
regulated by SMAC.  
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Materials and Methods 
Cel l  Culture 
The cell lines HeLa, HeLa-shXIAP, HeLa-shXIAP-mycXIAP and HeLa-shScr (Kashkar et al., 
2007; Seeger et al., 2010) as well as mouse embryonic fibroblasts (MEFs) of XIAP knockout 
mice (gift from D. Vaux, Victoria, Australia), BID knockout mice (gift from A. Villunger, 
Innsbruck, Austria) and SMAC/OMI double knockout mice (gift from M. Martins, Leicester, 
UK) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco (Invitrogen)) 
supplemented with 10% fetal calf serum (FCS, Gibco), 100 µg/ml streptomycin and 
100 units/ml penicillin (Biochrom AG, Berlin, Germany). 
 
Antibodies and reagents 
All chemicals used were acquired from Roth (Karlsruhe, Germany), Sigma (München, 
Germany) or Merck (Darmstadt, Germany), unless indicated otherwise. Staurosporine and 
z-VAD-FMK were obtained from Enzo Life Sciences (Lörrach, Germany), mTNF from 
Genentech (San Francisco, CA, USA), tri-DAP from Invivogen (Toulouse, France) and calpain 
inhibitor ALLN was obtained from Calbiochem (Darmstadt, Germany). 
Table 1: Primary and secondary antibodies used in western blotting 
Ant ibody Isotype Suppl ier 
β-Actin mouse, monoclonal Sigma (Deisenhofen, Germany) 
BAD rabbit, polyconal Cell Signaling (Frankfurt a.M., 
Germany) 
Bax (human) rabbit, polyclonal BD Bioscience (Heidelberg, 
Germany) 
Bak rabbit, polyclonal BD Bioscience (Heidelberg, 
Germany) 
BCL2 (clone 7) mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
BID rabbit, polyclonal BD Biosciences (Heidelberg, 
Germany) 
BIM rabbit, polyclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Calpain (clone P1) mouse, monoclonal Millipore (Schwalbach, Germany) 
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Caspase 8 (1C12) mouse, monoclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Caspase 9 rabbit, polyclonal Cell Signaling (Frankfurt a.M., 
Germany) 
cIAP1 goat, polyclonal R&D Systems (Wiesbaden, 
Germany) 
cIAP2 (clone 315304) mouse, monoclonal R&D Systems (Wiesbaden, 
Germany) 
Complex II (2E3GC12FB2AE2) mouse, monoclonal Invitrogen (Karlsruhe, Germany) 
Cyt c (clone 7H8.2C12) mouse, monoclonal BD Biosciences (Heidelberg, 
Germany) 
GFP rabbit, polyclonal Sigma (Deisenhofen, Germany) 
FLAG (clone M2) mouse, monoclonal Sigma (Deisenhofen, Germany) 
IκBα (C21) rabbit, monoclonal Santa Cruz (Heidelberg, Germany) 
NOXA (114C307) mouse, monoclonal Calbiochen (Darmstadt, 
Germany) 
HtrA2/Omi rabbit, polyclonal Cell Signaling (Frankfurt a.M., 
Germany) 
PARP (clone C2C10) mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
RIPK2 rabbit, polyclonal Santa Cruz (Heidelberg, Germany) 
Smac/Diablo (cat. 2954) mouse, monoclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Smac/Diablo (mouse) rabbit, polyclonal Millipore (Schwalbach, Germany) 
Ubiquitin (clone P4D1) mouse, monoclonal Cell Signaling (Frankfurt a.M., 
Germany) 
XIAP (clone 48) mouse, monoclonal BD Biosciences (Heidelberg, 
Germany) 
XIAP (2F1) mouse, monoclonal MBL (Eching, Germany) 
Anti-mouse IgG HRP-linked goat Sigma (Deisenhofen, Germany) 
Anti-rabbit IgG HRP-linked goat Sigma (Deisenhofen, Germany) 
Anti-goat IgG HRP-linked donkey Santa Cruz (Heidelberg, Germany) 
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Table 2: Primary and secondary antibodies for immunofluorescence 
Ant ibody Isotype Suppl ier 
Cytochrome c Alexa Fluor 555-
conjugated 
mouse, monoclonal Invitrogen (Karlsruhe, Germany) 
S. flexneri serotype 5 LPS rabbit, polyclonal gift from P. Sansonetti  
(Paris, France) 
Smac/Diablo (clone 7) mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
Alexa Fluor 405 goat Invitrogen (Karlsruhe, Germany) 
Alexa Fluor 488 mouse Invitrogen (Karlsruhe, Germany) 
 
DNA constructs 
Ub-SMAC and SMACΔMTS were previously described (Kashkar et al., 2006). pUNO-IKKβ 
was obtained from Invivogen (Toulouse, France). RIP2-VSV was a kind gift from Margot 
Thome (Lausanne, Switzerland). pcDNA3.1-NOD1 was a kind gift from Gabriel Nuñez (Ann 
Arbor, MI, USA). FLAG-NOD1 was previously described (Kufer et al., 2006). For the 
construction of BID-GFP-fusion proteins, open reading frames (ORF) encoding human BID, 
cleaved by caspase-8 (BIDcasp8) and BID cleaved by calpain (BIDcalp), were amplified by PCR 
and cloned into pEGFP-C3 vector (Clontech, Saint-German-en-Laye, France). Primers are 
listed in table 3.  
Table 3: Primers for DNA-constructs 
Name Sequence 
BIDcasp8 forward 5’ - ccc ccc aag ctt atg ggc aac cgc agc agc cac tcc c - 3’ 
BIDcalp forward 5’ - ccc ccc aag ctt atg aga ata gag gca gat tct gaa ag - 3’ 
BID reverse 5’ - ccc ccc gga tcc tca gtc cat ccc att tct ggc taa gc - 3’ 
 
Bacterial infection 
Bacterial infection of the indicated cells was performed using the S. flexneri strain M90T afaE 
as described previously (Philpott et al., 2000). M90T afaE is a wild-type (WT) invasive strain of 
S. flexneri serotype 5a harboring the plasmid pIL22, which encodes the afimbrial adhesin 
from uropathogenic Escherichia coli to allow better synchrony of infection (Clerc and 
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Sansonetti, 1987). The invasion plasmid cured strain S. flexneri BS176 was used as non-
invasive control (both strains were kindly provided by P. Sansonetti, Paris, France). Overnight 
cultures of S. flexneri strains were diluted 1/20 in trypticase soy broth (BD Bioscience, 
Heidelberg, Germany) and grown to an optical density of 0.3 at 37°C. Prior to infection, cells 
were starved in DMEM without FCS for 1 h followed by incubation with S. flexneri (MOI = 30) 
for 15 min at RT and transferred to 37°C for 30 min (time point zero). Plates were then 
transferred into fresh DMEM containing 10% FCS and 50 µg/ml gentamycin to kill 
extracellular bacteria.  
 
Gentamycin protection assay 
Uptake of S. flexneri in different cell lines was analysed by lysis of pellets of infected cells in 
0.5% SDS/ H2O. Serial dilutions of cell lysates were plated onto trypticase soy broth bacto 
agar plates without antibiotics and incubated at 37°C for 24 h. Colonies were counted and 
the recovery was determined as colony forming units (cfu). 
 
Cel l  v iabi l i ty and cel l  death 
HeLa cells (1 x 104) were incubated in 96-well plates at 37°C in full medium and infected with 
S. flexneri at the indicated MOI and incubation time. Cell viability was assessed by the Cell 
Proliferation Kit II (XTT) (Roche Applied Sciences, Mannheim, Germany) according to the 
instructions of the manufacturer. Briefly, cells were incubated with the XTT reagents at 37°C 
for 4 h. The absorbance of the samples was measured with an enzyme-linked 
immunosorbent assay (ELISA) reader (wavelength 450 nm; reference wavelength 620 nm). 
The data are mean values from at least three different experiments in triplicate. Values of 
absorbance of untreated cells (after background subtraction) were set as 100 % viability. 
Cell death was assessed by trypan blue exclusion using an automated cell counter 
(CountessTM, Invitrogen, Karlsruhe, Germany).  
 
NF-κB activity  
For EMSA, nuclear extracts were prepared as described (Haubert et al., 2007). Briefly, 10 µg 
extract were preincubated in binding buffer (5 mM Hepes, pH 7.8, 5 mM MgCl2, 50 mM KCl, 
0.2 mM EDTA, 0.5 mM dithiothreitol, 10% glycerol) with 500 ng of poly dI:dC 
(GE Healthcare, Freiburg, Germany) for 20 min at RT. NF-κB-specific radiolabelled probe 
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HIV-LTR (wt) 5-ATCAGGGACTTTCCGCTGGGGACTTTCCG-3 and the unrelated 
oligonucleotide HIV-LTR (mu) lacking the κB site 5'-GATCACTCACTTTCCGCTTGCTCACTT 
TCCAG-3` (1-5 x 104 cpm) were added and the reaction was incubated for 7 min at RT. 
Samples were resolved on a 6% polyacrylamide gel by electrophoreses in low ionic strength 
buffer (0.25x TBE). Gels were dried (Slab gel dryer, Biorad) and analysed by 
autoradiography.  
ELISAs were performed after nuclear extraction using the TransAM® NFκB p65 Kit (Active 
motif, Rixensart, Belgium) according to the instructions of the manufacturer. Read out was 
performed on an ELISA reader (Anthos HT2) at a wavelength of 450nm/620nm. 
 
Cel l  fractionation, sample preparation and Western blott ing 
For whole cell lysates appropriate cell numbers were incubated in CHAPS buffer on ice for 
20 min followed by centrifugation at 14.000 x g for 30 min to recover the supernatant. To 
obtain nuclear fractions the CHAPS-pellets were resuspended in urea extraction buffer and 
denatured at 95°C for 5 min. For cytosolic extracts cells were incubated in HEP buffer on ice 
for 20 min and mechanically disrupted by repeated passage (15x) through a 26 G x ½’’ 
needle. Mitochondria were isolated using the Mitochondria-Isolation-Kit according to the 
instructions of the manufacturer (Miltenyi Biotec, Bergisch Gladbach, Germany) (Hornig-Do 
et al., 2009). For Western blotting, equal amounts of protein were resolved by SDS-PAGE 
and transferred onto nitrocellulose membrane (Protran, Schleicher & Schuell) followed by 
incubation with the appropriate primary and secondary antibodies (table 1).  
Table 4: Buffers for sample preparation and Western blotting 
CHAPS lysis buffer 10 mM HEPES, pH 7.4, 150 mM NaCl, 1% CHAPS, 
protease complete cocktail 
Urea extraction buffer 50 mM Tris (pH 6.8), 6 M urea, 3% SDS, 10% glycerol, 
0.00125% bromphenol blue, 5% 2-mercaptoethanol 
HEP buffer 20 mM Hepes, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 
1 mM EDTA, 10 µM cytochalasin B, 1 mM DTT, 
protease inhibitor 
SDS running buffer 14.4 % (w/v) Glycin, 3 % (w/v) Tris Base, 0.1% (w/v) 
SDS 
Laemmli sample buffer (5 x)  0,6 M Tris-HCL pH 6.8, 144 mM SDS, 25 % (v/v) 
Glycerol, 0.1% (w/v) Bromophenol blue, 5% (v/v) 
β-Mercaptoethanol 
Blot transfer buffer 25 mM Tris base pH 8.3, 192 mM Glycin, 20 % (v/v) 
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Methanol 
Blocking buffer 10 mM Tris-HCl pH 7.4 – 7.6, 150 mM NaCl, 5 % (w/v) 
skim milk powder, 2 % (w/v) BSA, 0.1 % (v/v) 
Tween-20 
Antibody dilution buffer 50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% Tween-20, 
5% BSA 
S-PBS 1.2 M NaCl, 0.1 M NaH2PO4, 0.3 M  K2HPO4, pH 7.6  
 
Immunoprecipitat ion of active BAX 
200 µg of whole cell lysates were brought to a final volume of 500 ml with CHAPS lysis 
buffer. KCl was added to a final concentration of 150 mM. Samples were incubated for 12 h 
at 4°C with 2 μg of monoclonal anti-Bax 6A7 antibody (BD Biosciences, Heidelberg, 
Germany). Antigen-antibody complexes were immobilized on GammaBind G Sepharose (GE 
Healthcare, Freiburg, Germany) by rotation for 2 h at 4°C. The complexes were pelleted 
(1 min, 14 000 x g) and the supernatant removed. The complexes were then washed three 
times with CHAPS/150 mM KCN and subjected to SDS-PAGE and Western blotting as 
described above. 
 
RNAi interference 
For siRNA mediated knock-down, HeLa cells were transfected with 200 pmol/μl siRNA using 
LipofectamineTM RNAiMAX transfection reagent (Invitrogen, Karlsruhe, Germany). Cells were 
incubated for 48 h prior to infection with S. flexneri. 
Table 5: siRNAs used in this work 
s iRNA Sequence Suppl ier 
BID sense: 5’ - cuugcuccgugaugucuuutt - 3’ Ambion (Darmstadt, Germany) 
BAD sense: 5’ - guacuucccucaggccuau - 3’ Ambion (Darmstadt, Germany) 
BIM sense: 5’ - ccucccuacagacagagcctt - 3’ Ambion (Darmstadt, Germany) 
NOXA sense: 5’ - ggugcacguuucaucaauu - 3’   Ambion (Darmstadt, Germany) 
Scr All star non targeting mix QIAGEN (Hilden, Germany) 
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Caspase-3 activ ity 
30 µg cytosolic extracts (prepared with 0.1 µM PMSF instead of protease inhibitor) were 
treated with increasing amounts of horse heart Cyt c as indicated and in combination with 
1 mM dATP for 1 h at 30°C. For caspase-activity measurement, cytosolic extracts were filled 
up to a total volume of 100 µl with caspase activation buffer (20 mM Pipes, 100 mM NaCl, 1 
mM EDTA, 0.1% CHAPS, 10 % sucrose, 10 mM dithiothreitol). The reaction was initiated by 
the addition of the fluorometric substrate 100 µM Ac-DEVD-7-amino-4-
trifluoromethylcomarin (Ac-DEVD-AFC, Axxora, Lörrach, Germany), followed by readout at 
400/505 nm using a Tecan GENious Pro (Tecan, Crailsheim, Germany). Caspase activity is 
presented as arbitrary fluorescence units per minute (FU/min); 1 FU is equivalent to 
0.65 pmol released AFC. 
 
Mitochondrial membrane potential  
For analysis of mitochondrial membrane potential HeLa cells were stained with 10 µM JC-1 
(Invitrogen, Karlsruhe, Germany) for 30 min at 37°C and analysed by flow cytometry. For the 
analysis by confocal microscopy, HeLa cells were seeded on cover slips and stained with 
25 nM MitoTracker® Red CMXRos (Invitrogen) in culture media at 37°C for 30 min.  
 
Microscopy 
For immunofluorescence analyses, HeLa cells (2 x 105) were fixed with 
3% paraformaldehyde, permeabilised for 30 min and blocked with blocking buffer for 30 min 
(table 6) Cells were incubated with the appropriate primary antibody in blocking buffer over 
night at 4°C. Cells were washed twice for 5 minutes with blocking buffer and incubated with 
secondary antibody for 1 h at room temperature. Cells were washed twice with blocking 
buffer and once with PBS for 5 minutes (table 2). Cover slides were mounted using Mowiol 
mounting medium. Imaging was performed on an UltraView VoX Spinning Disk Confocal 
microscope (Perkin Elmer, Rodgau, Germany) with a piezoelectric z-axis motorized stage, 
excited using the appropriate laser lines. For confocal images, z-axis stacks were acquired 
with a 60x TIRF Oil NA 1.49 objective. 
For transmission electron microscopy analyses, cells were washed in phosphate buffer, fixed 
in fixation buffer and collected as cell pellets after centrifugation (table 6). Cell pellets were 
then postfixed with osmium tetroxide, and embedded in Epon (Fluka, Buchs, Switzerland). 
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Ultrathin sections were cut using a Leica Ultracut EM UC6 (Wetzlar, Germany) and 
micrographs were obtained using a Philips CM 10 transmission electron microscopy.  
For phase contrast imaging, HeLa cells (2 x 105) were seeded onto cover slips and infected 
with S. flexneri at MOI 30. After infection cells were fixed with 3% paraformaldehyde and 
cover slips were mounted on microscope slides using Mowiol mounting medium. Imaging 
was performed on an Axioplan II fluorescence microscope (Zeiss, Jena, Germany). 
Table 6: Buffers and sample preparation for microscopic analysis 
Permeabilization buffer 0.1% Saponin, PBS 
Blocking buffer 3% BSA, 0.1% Saponin, PBS 
Mowiol 10% Mowiol, 25% Glycerol, 0.1 M Tris, 2.5% DABCO, 
H2O 
Phosphate buffer 0.12 M phosphate in H2O 
Fixation buffer  2% glutaraldehyde, 0.12 M phosphate buffer 
 
 
Mouse strains 
XIAP-deficient mice (Xiap/ICS/IR2785b/E114/2785c) were obtained from EUCOMM (The 
European Conditional Mouse Mutagenesis Program, ICS, Illkirch, France). For the generation 
of 'Knockout-first allele' XIAP knockout mice an L1L2-Bact-P cassette was inserted at 
position 39451542 of Chromosome X upstream of exon 3. The cassette is composed of an 
FRT site followed by a lacZ sequence and a loxP site. This first loxP site is followed by 
neomycin under the control of the human β-actin promoter, SV40 polyA, a second FRT site 
and a second loxP site. A third loxP site is inserted downstream of the targeted exon (exon 
3) at position 39452298. Exon 3 is thus flanked by loxP sites. A "conditional ready" (XIAPfl/fl) 
allele was created by crossbreeding with Flp-deleter mice (Flp recombinase expressing mice) 
(Dymecki, 1996). Subsequent crossbreeding with AFP-Cre mice (Kellendonk et al., 2000) 
resulted in a liver specific knockout mouse (XIAPliver-/-). Like the conventional XIAP knockout 
mouse (Harlin et al., 2001) our XIAP knockout (Knockout-first allele) and liver specific XIAP 
knockout mice do not appear to have striking phenotypic defects. SMAC/OMI knockout  
mice (C57BL/6J background) were obtained from M. Martins (Leicester, UK) (Martins et al., 
2004). BID knockout mice (C57BL/6J background) were obtained from T. Kaufmann (Bern, 
Switzerland) (Kaufmann et al., 2007). 
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Infection of mice with  S. f lexneri 
Mice received food and water ad libitum. Overnight cultures of S. flexneri strains M90T or 
BS176 were prepared as described and resuspended in sterile PBS to obtain the indicated 
concentrations. Mice were challenged by injection of the caudal vein with the bacterial 
suspension. Cages were inspected every 2-3 h and deaths were recorded for 4 consecutive 
days or the animals were sacrificed by cervical dislocation at the desired time points. The 
liver was then removed, imaged with a SC 100 digital colour camera (Olympus, Hamburg, 
Germany) or prepared for immunohistochemical staining. 
 
Tissue immunohistochemistry ( IHC)  
Livers from infected mice were fixed in 4% paraformaldehyde over night. Whole livers were 
processed using an ASP300 S Tissue Processor (Leica, Wetzlar, Germany). Embedded 
samples were cut using a sliding microtome HM 400 (Thermo Scientific, Fisher Scientific 
GmbH, Schwerte, Germany) to produce 5  μm thick sections. Staining with 
haematoxylin/eosin (Thermo Scientific, Fisher Scientific GmbH) or mouse-anti-F4+/80+ 
antibody (AbD serotec, Düsseldorf, Germany) was performed.  
 
Stat ist ical analysis 
Data are presented as means of at least three independent experiments. Standard deviations 
were calculated as indicated in the figures legends. Two-tailed student’s t-test was applied 
for statistical analyses. P-values for the Kaplan Meier survival curves were calculated using 
chi-square statistics. 
 
Software 
Plasmids      Vector NTI Suite 
Grafical software     Adobe Photoshop CS4 
       Adobe Illustrator CS5  
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Results 
XIAP is required for S. f lexneri- induced NF-κB activat ion 
Increasing evidence implicates XIAP in immune responses, such as NOD signalling, in 
addition to its well-known function in apoptosis (Gyrd-Hansen and Meier, 2010). A well-
studied physiological model for the activation of NOD1-mediated NF-κB signalling is the 
infection of cultured epithelial cells with the Gram-negative bacterium S. flexneri (Girardin et 
al., 2001). To address whether XIAP is required for the cellular immune responses towards 
S. flexneri, HeLa cell lines stably expressing a XIAP-specific short hairpin RNA (HeLa-shXIAP) 
or a non-targeting control shRNA (HeLa-shScr) (Figure 6A) were infected with the invasive 
strain S. flexneri M90T (in the following referred to as S. flexneri). XIAP knockdown resulted in 
markedly reduced NF-κB activation in response to S. flexneri, as examined by 
electrophoretic mobility shift assay (EMSA) (Figure 6B). Reintroduction of XIAP by stable 
overexpression of myc-tagged XIAP (lacking the 3’ UTR, which targeted by the stable 
shRNA) in XIAP-deficient HeLa cells (HeLa-shXIAP-mycXIAP) restored NF-κB activation 
(Figure 6B). In contrast to S. flexneri infection, stimulation of Hela cells with TNF, induced 
NF-κB activation even in the XIAP-deficient HeLa cells (Figure 6B). Since the NOD1- and 
TNF-signalling cascade share the signalling pathway downstream of the IKK complex, this 
confirms that NF-κB signalling in general is not defective in HeLa-shXIAP cells. To exclude 
the possibility that different invasion rates of S. flexneri into the cell account for the reduction 
in NF-κB activation in XIAP knockdown cells, we showed that the invasion rates in the 
HeLa wt and HeLa-shXIAP cells were similar by performing a gentamycin protection assay 
(Figure 6C). 
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Figure 6. XIAP is required for S. f lexner i- induced NF-κB act ivat ion in HeLa cel ls.  
(A) Expression levels of XIAP and cIAP1/2 in HeLa wt, HeLa shScr, HeLa shXIAP (expressing shRNA 
targeting the 3’ UTR of XIAP) and HeLa shXIAP-mycXIAP (expressing mycXIAP lacking the 3’ UTR of 
XIAP) were analysed by Western blotting. 
(B) HeLa cell lines were either left untreated (-) or were infected with S. flexneri M90T (S.f.) (MOI 30) 
(upper panel) or stimulated with TNF (10 ng/ml, 30 min) (lower panel). NF-κB (p65) DNA binding 
activity was analysed by EMSA at the indicated time points post infection (p.i.). 
(C) HeLa wt, HeLa shScr, HeLa shSMAC and HeLa shXIAP cells were infected with S.flexneri M90T 
(S.f.) (MOI 30). Cells were lysed 6 h p.i. and indicated dilutions were plated on trypticase soy broth 
bacto agar plates. Colony forming units were counted. Error bars represent mean ± SD (n=2).  
 
In line with the data obtained in HeLa cell lines, S. flexneri-induced NF-κB activation was 
barely detectable in mouse embryonic fibroblasts (MEFs) derived from XIAP knockout mice, 
whereas significant NF-κB activation was observed in wild type MEFs upon infection 
(Figure 7A and 7B). In contrast to S. flexneri-induced NF-κB activation, the lack of XIAP 
expression did not impair TNF-induced NF-κB activation in XIAP knockout MEFs (Figure 7A, 
lower panel). 
 
F igure 7. XIAP is required for S. f lexner i- induced NF-κB act ivat ion in MEFs. 
(A) MEFs isolated from wild type (wt) or XIAP-/- mice were infected with S. flexneri (S.f.) (MOI 30) (upper 
panel) or treated with TNF (10 ng/ml) (lower panel). NF-κB (p65) DNA binding activity was analysed by 
EMSA at the indicated time points p.i..  
(B) Expression levels of XIAP in XIAP-/- and wt MEFs were analysed by Western blotting. 
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Together these data identify XIAP as an indispensable component of the pro-inflammatory 
signalling in response to intracellular S. flexneri. 
 
S. f lexneri- induced release of mitochondrial SMAC interrupts 
NOD1/XIAP-mediated inf lammatory signal l ing  
Although the intracellular presence of S. flexneri potently induced NF-κB activation, NF-κB 
activity declined significantly 6 h post infection (p.i.) (Figure 6B and 7A). This was not due to 
the cytolytic activity of intracellular S. flexneri as detailed cell viability measurements failed to 
show any significant cell death up to 12 h p.i., which was further supported by phase 
contrast microscopy (Figure 8A and 8B).  
 
 
F igure 8. Cel l  v iabi l i ty is not affected upon ear ly S. f lexner i  infect ion. 
(A) HeLa wt cells were left untreated or were infected with S.flexneri with the indicated MOI. Cell death 
and cell viability were determined at the indicated time points by trypan blue exclusion (cell death) and 
XTT (viability). Error bars represent mean ± SD (n=3). 
(B) HeLa wt cells were left untreated (ctrl) or were infected with S.flexneri (MOI 30). At the indicated 
time points cells were fixed and imaged by bright field microscopy. Arrows point to intracellular 
S. flexneri. (scale bar = 10 μm) 
 
Interestingly, initial data concerning the role of XIAP in cellular immune inflammatory signalling 
showed that SMAC mimetics can disrupt NOD-mediated NF-κB activation in HeLa cells by 
antagonising XIAP (Krieg et al., 2009; Bertrand et al., 2011). However, the physiological 
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relevance of XIAP and its antagonisation by cellular SMAC with regard to inflammatory 
signalling remained unresolved. We hypothesised that inhibition of XIAP by its cellular 
antagonists could represent a yet unrecognised, cellular regulatory mechanism, hijacked by 
S. flexneri to escape immune detection. We therefore examined whether S. flexneri triggered 
the release of the mitochondrial XIAP antagonists, SMAC and OMI, to intercept XIAP-
mediated NF-κB-activation. Detailed kinetics of S. flexneri-induced NF-κB activation showed 
a gradual decline in NF-κB activity 3 h p.i. (Figure 9, upper and middle panel). Western blot 
analysis of cytosolic fractions of infected HeLa cells revealed that SMAC and OMI 
accumulated in the cytosol in a time frame exactly corresponding to the decline of NF-κB 
activity (Figure 9, lower panel). These data suggest that S. flexneri is capable of usurping 
intracellular mechanisms to antagonise XIAP for the purpose of inhibiting NF-κB activation 
and preventing an anti-bacterial immune response, respectively. 
 
 
F igure 9. SMAC accumulates in the cytosol in response to S. f lexner i .  
HeLa wt cells were either left untreated (-) or infected with S. flexneri (S.f.) (MOI 30). NF-κB DNA 
binding activity was analysed by EMSA at the indicated time points p.i. (upper panel). Densitometric 
quantification of NF-κB DNA binding activity of five independent experiments (middle panel). Cytosolic 
fractions from the same experiment were analysed by Western blotting (lower panel). Error bars 
represent mean ± SEM (n=5) 
 
To investigate the role of SMAC in inflammatory signalling upon S. flexneri infection, a stable 
HeLa cell line with specific knock-down of SMAC was used (HeLa-shSMAC, Figure 10B). As 
shown in Figure 10A, NF-κB activity (measured by EMSA and ELISA) increased within 3 h p.i. 
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and persisted through later time points in cells lacking SMAC but not in HeLa controls (HeLa-
shScr). Likewise, NF-κB activation was more persistent in SMAC/OMI double knockout 
MEFs than in wild type MEFs (Figure 10C). These findings confirm that SMAC and OMI 
negatively regulate NF-κB activity after infection with S. flexneri by antagonisation of XIAP.  
 
 
F igure 10. SMAC- and OMI-def ic ient cel ls show increased NF-κB act iv i ty upon 
S. f lexner i  infect ion. 
(A) HeLa shScr or HeLa shSMAC cells were either left untreated (-) or infected with S. flexneri (S.f.) 
(MOI 30). NF-κB DNA binding activity was analysed by EMSA at the indicated time points p.i.. (upper 
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panel). Densitometric quantification of NF-κB DNA binding activity of five independent experiments 
(middle panel). NF-κB activity was analysed by ELISA (lower panel). **p <0.01 
(B) Expression levels of SMAC, OMI and Cyt c in HeLa shScr and HeLa shSMAC cells were analysed 
by Western blotting. 
(C) MEFs isolated from wild type (wt) or SMAC-/-/OMI-/- mice were either left untreated (-) or infected 
with S. flexneri M90T (S.f.) (MOI 50). Cytosolic fractions were analysed by Western blotting at the 
indicated time points p.i. (upper panel, * marks unspecific band). NF-κB activity was analysed by 
ELISA at the indicated time points p.i. (lower panel). Error bars represent mean ± SEM (n=4).  
 
 
Of note, unlike intracellular S. flexneri, activation of the NOD1 signalling cascade by 
overexpression of NOD1, Tri-DAP-induced activation of NOD1 or overexpression of RIPK2 
did not induce the release of SMAC into the cytosol (Figure 11).  
 
 
 
F igure 11. NOD1 act ivat ion does not induce the cytosol ic accumulat ion of SMAC. 
HeLa wt cells were either left untreated (ctrl) or transfected with expression vectors encoding NOD1-
Flag or RIP2-VSV. After 24 h, cells were stimulated with Tri-DAP (10 µg/ml) (+) or were infected with 
S. flexneri (MOI 30) for 6 h. Cytosolic fractions were prepared and analysed by Western blotting. 
 
 
These data suggest that S. flexneri employs more complex cellular mechanisms than NOD1 
stimulation alone, to induce the release of mitochondrial SMAC and OMI in order to 
antagonise XIAP and therefore intercept the XIAP-mediated cellular inflammatory responses. 
  
cytosolic SMAC
IκBα
FLAG
β-Actin
RIPK2
43 kDa
17 kDa
43 kDa
95 kDa
55 kDa
ctr
l
NO
D1
-FL
AG
NO
D1
-FL
AG
S. 
fle
xn
eri
RIP
K2
-VS
V 
ctr
l 
++Tri-DAP:
WB
  RESULTS 
                   
 
29 
Intracel lular S. f lexneri induces the release of mitochondrial SMAC 
without inducing col lateral cel lular damage 
Many enteroinvasive bacterial pathogens interfere with the cellular death machinery in order 
to modulate host defense mechanisms and to ensure bacterial survival and propagation 
(Lamkanfi and Dixit, 2010). In particular, S. flexneri-infected epithelial cells have been shown 
to remain alive during early stages of infection (Mantis et al., 1996). In line with these 
observations, our data show that S. flexneri induced the release of SMAC and OMI to 
intercept XIAP-mediated inflammatory response without inducing a cytotoxic effect for up to 
12 h p.i. (Figure 8 and 9).  
According to the current dogma, mitochondrial outer membrane permeabilisation involves 
the simultaneous release of intermembrane space (IMS) proteins including SMAC, OMI and 
Cytochrome c (Cyt c) into the cytosol where the latter then initiates the proteolytic activation 
of caspases to induce apoptosis. Indeed pro-apoptotic stimuli such as UV light or 
staurosporine (STS) induced the release of mitochondrial SMAC and OMI into the cytosol, 
accompanied by the co-release of Cyt c (Figure 12A, upper panel). Infection with S. flexneri, 
however, induced the release of mitochondrial SMAC and OMI, but not Cyt c, which was 
barely detectable in the cytosol (Figure 12A, upper panel). Without cytosolic Cyt c, 
S. flexneri-infected cells failed to activate the caspase cascade as shown by the lack of 
caspase-9 processing, caspase-3 activity and PARP cleavage (Figure 12A, middle panel). 
BAX activation has been viewed as an immediate early event preceding mitochondrial outer 
membrane permeabilisation in apoptotic cells (Kashkar et al., 2005). In striking contrast to 
apoptotic stimuli, the release of SMAC and OMI in S. flexneri-infected cells was not 
accompanied by BAX activation (Figure 12A, lower panel) suggesting that S. flexneri induces 
mitochondrial outer membrane permeabilisation in a non-apoptotic manner. These data were 
confirmed by confocal microscopy of S. flexneri-infected HeLa cells (Figure 12B). Specifically, 
the distribution of SMAC in infected cells was diffuse and cytosolic, whereas Cyt c-staining 
remained confined to a typical mitochondrial pattern 4 h p.i.. In contrast, in cells treated with 
UV light or STS, both SMAC and Cyt c appeared in the cytosol. Importantly, the 
accumulation of SMAC and OMI in the cytosol of S. flexneri-infected cells was mirrored by a 
reduction of SMAC and OMI in the mitochondrial fraction, whereas no significant reduction in 
mitochondrial Cyt c was detectable (Figure 12C). 
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F igure 12. SMAC and OMI are select ively re leased from mitochondria upon S. f lexner i  
infect ion. 
(A) HeLa wt cells were either left untreated (-), treated with UV-light (10 mJ/m2), STS (0.5 µM) or were 
infected with S. flexneri (S.f.) (MOI 30). After 4 h SMAC, OMI, Cyt c and caspase-9 were analysed in 
the cytosolic fractions by Western blotting. PARP cleavage was analysed in nuclear fractions by 
Western blotting. Caspase-3 activity was determined fluorimetrically in cytosolic fractions using the 
substrate Ac-DEVD-AFC (middle panel). Activated BAX was immuniprecipitated and analysed by 
Western blotting. Total amount of BAX protein was analysed in total cell lysates (lower panel). Error 
bars represent mean ± SEM (n=3). 
(B) HeLa cells were treated as in (A). After 4 h, SMAC (green), Cyt c (red) and S. flexneri (blue) were 
stained and analysed by confocal microscopy. (scale bar = 20 µm) 
(C) HeLa wt cells were treated as in (A). Mitochondria were isolated and analysed at the indicated time 
points by Western blotting. Complex II (flavoprotein subunit) served as a loading control. 
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In contrast to soluble IMS proteins including SMAC and OMI, the release of mitochondrial 
Cyt c requires additional biochemical or structural modifications of the mitochondrial inner 
membrane to mobilise the cristae-endowed Cyt c into the mitochondrial IMS and to facilitate 
the release of Cyt c from the mitochondrial IMS into the cytosol upon mitochondrial outer 
membrane permeabilisation (Martinou and Youle, 2006). Accordingly, an elevated 
mitochondrial membrane potential (ΔΨm) due to either accelerated mitochondrial respiratory 
activity or a pH-gradient prevents efficient Cyt c-release (Gottlieb et al., 2003). In S. flexneri-
infected cells, Cyt c is retained in the mitochondria (Figure 12C) indicating a lack of 
overwhelming mitochondrial damage at early stages of infection. We therefore asked 
whether the ΔΨm was maintained in S. flexneri-infected cells. In contrast to STS-treatment, 
which depleted the ΔΨm, S. flexneri-infection had no effect on ΔΨm, analysed by FACS and 
mitotracker staining (Figure 13A and 13B). In addition, electron micrographs showed that the 
cristae integrity of the inner mitochondrial membrane was preserved after infection with 
S. flexneri, but not after treatment with STS (Figure 13C). We conclude that the maintained 
ΔΨm is responsible for the retention of Cyt c inside the mitochondria of infected cells.  
 
 
F igure 13. Mitochondria remain intact after infect ion with S. f lexner i .  
(A) HeLa wt cells were either left untreated (ctrl), infected with S.flexneri (S.f.) (MOI 30) or treated with 
STS (0.5 µM). ΔΨm was analysed after JC-1 staining at the indicated time points using FACS analysis. 
CCCP was used as a reference for complete depletion of ΔΨm. Error bars represent mean ± SEM 
(n=3); *p<0.05  
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(B) HeLa wt cells were treated as in (A) and were stained with Mitotracker after 6 h. In confocal 
images, S.f. was visualized by indirect immunofluorescence (blue) and nuclei were stained with DAPI 
(blue). (scale bar = 8 µm). 
(C) HeLa wt cells were treated as in (A) and mitochondrial cristae structure was analysed by 
transmission electron microscopy. Arrows indicate mitochondria (M) or S. flexneri (S.f.). (scale bar = 
300 nm (ctrl, S.f.); 1 µm (STS)). Electron micrographs were performed in collaboration with Paola 
Martinelli. 
 
 
To investigate this further, S. flexneri-infected cells were treated with the mitochondrial 
uncoupler CCCP in order to deplete ΔΨm and cytosolic appearance of Cyt c was monitored 
by Western blotting. Upon CCCP treatment, mitochondrial Cyt c was released into the 
cytosol of infected cells, demonstrating the dependence of Cyt c release on ΔΨm (Figure 
14A). Of note, in uninfected control cells, CCCP alone did not lead to Cyt c release, 
indicating that in S. flexneri-infected cells Cyt c is merely retained in already permeabilised 
mitochondria by the maintenance of ΔΨm. The retention of Cyt c in the mitochondria likely 
prevents an apoptotic demise of S. flexneri-infected cells. Indeed, addition of recombinant 
Cyt c to cytosolic extracts of infected cells potently induced caspase-3 activity (Figure 14B).  
 
 
F igure 14. Cyt c re leased from depolar ised mitochondria induces caspase act iv i ty. 
(A) HeLa wt cells were either left untreated (-) or were infected with S. flexneri (S.f.) (MOI 30) with or 
without CCCP co-treatment (+) (50 µM, 1 h). Cytosolic fractions were analysed at the indicated time 
points by Western blotting. 
(B) HeLa shScr and HeLa shSMAC cells were left untreated or were infected with S. flexneri (S.f.) (MOI 
30) and were treated with the indicated concentrations of recombinant Cyt c. Caspase-3 activity was 
determined fluorimetrically in cytosolic fractions using the substrate Ac-DEVD-AFC. Error bars 
represent mean ± SEM (n=3). Caspase-3 activity measurement was performed by Jens Seeger. 
 
Of note, caspase-3 activity after addition of recombinant Cyt c was more noticeable in 
infected than in non-infected cells, presumably caused by the cytosolic presence of SMAC in 
the cytosol of S. flexneri-infected cells, which antagonises XIAP and therefore liberates 
caspases from its inhibition by XIAP. Indeed, recombinant Cyt c-induced caspase activity 
was lower in cytosolic extracts derived from infected HeLa-shSMAC cells (Figure 14B). 
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Accordingly, these data suggest that S. flexneri-infected cells, by accumulating cytosolic 
SMAC are primed to undergo apoptotic cell death. This is efficiently prevented by 
maintaining the ΔΨm that retains Cyt c inside the mitochondria. 
In conclusion our data show, that the mitochondria of S. flexneri-infected cells, despite an 
overwhelming intracellular bacterial load, retain their membrane potential to ensure 
mitochondrial integrity and prevent apoptosis. 
 
Calpain-cleaved BID induces the mitochondrial release of SMAC 
in S. f lexneri–infected cel ls 
In apoptotic cells the release of IMS proteins is regulated by members of the BCL2 protein 
family, comprised of pro- and anti-apoptotic members that are functionally controlled by a 
third divergent class of BH3-only proteins (Youle and Strasser, 2008). In order to investigate 
the regulation of S. flexneri-induced SMAC release, we analysed the expression and the 
mitochondrial association of BCL2 proteins in S. flexneri-infected cells (Figure 15A). The 
BH3-only protein BID was specifically detected in the mitochondrial fractions isolated from 
S. flexneri-infected cells, revealing a fragment significantly smaller than full-length BID. The 
specific detection of BID was confirmed by disappearance of the detected BID fragment 
after siRNA-mediated downregulation (Figure 15B). 
 
F igure 15. BID translocates to the mitochondria upon S. f lexner i  infect ion. 
(A) HeLa wt cells were either left untreated (-) or were infected with S. flexneri (S.f.) (MOI 30). At the 
indicated time points total lysates and isolated mitochondria were analysed by Western blotting. 
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(B) HeLa wt cells were transiently transfected with BID-specific siRNA or non-targeting ctrl (siScr).  
After 48 h cells were infected with S. flexneri (S.f.) (MOI 30) for 6 h. Total lysates were analysed by 
Western blotting. 
 
Interestingly, specific knockdown of BID, but not of other BH3-only proteins including BAD, 
BIM or NOXA, impaired the S. flexneri-induced release of SMAC, suggesting the involvement 
of BID in this process (Figure 16A). In addition, S. flexneri infection failed to induce SMAC 
release in MEFs derived from BID knockout mice (Figure 16B). 
 
 
 
F igure 16. SMAC release is reduced in BID-def ic ient HeLa cel ls and MEFs. 
(A) HeLa wt cells were transiently transfected with different siRNAs specific for BID, BAD, BIM, NOXA 
or scrambled ctrl. After 48 h cells were infected with S. flexneri (S.f.) (MOI 30) for 6 h. Cytosolic 
extracts and total lysates were analysed by Western blotting.  
(B) MEFs isolated from wild type (wt) or from BID-/- mice were either left untreated (-) or were infected 
with S. flexneri (S.f.) (MOI 50). Cytosolic extracts were analysed by Western blotting at the indicated 
time points p.i..  
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BID has been shown to be proteolytically processed by active caspase-8 in response to 
death receptor ligation (Li et al., 1998; Luo et al., 1998). Caspase-8-cleaved BID then 
translocates to the mitochondria where it leads to mitochondrial membrane permeabilisation 
through the formation of the BAX/BAK pore. However, BAX was not activated upon 
S. flexneri infection and caspase activity was not detectable (Figure 12A). Accordingly, a 
protease different from caspase-8 might be responsible for the proteolytic cleavage of BID in 
response to S. flexneri infection. The calpain protease has been shown to potently cleave 
BID (Billen et al., 2008) and calpain was recently shown to be activated by intracellular 
S. flexneri (Bergounioux et al., 2012). In line with this, we also observed calpain activation 
upon S. flexneri infection (Figure 17A). The observation that calpain can cleave BID is 
supported by our data that inhibition of the proteolytic activity of calpain in S. flexneri cells 
with the calpain inhibitor ALLN suppressed BID truncation (Figure 17B). Consequently, 
treatment of S. flexneri-infected cells with ALLN prevented SMAC release (Figure 17C). Of 
note, caspase inhibition with the pan-caspase inhibitor zVAD did not block SMAC release 
after S. flexneri infection (Figure 17C).  
 
 
F igure 17. BID is proteolyt ical ly c leaved by calpain after S. f lexner i  infect ion. 
(A) HeLa wt cells were either left untreated (-) or were infected with S. flexneri (S.f.) (MOI 30). At the 
indicated time points total lysates were analysed by Western blotting. 
(B) HeLa wt cells were incubated with calpain inhibitor ALLN (1 nM). After 1 h pre-incubation, cells 
were infected with S. flexneri M90T (S.f.) (MOI30). Mitochondrial fractions were analysed by Western 
blotting at the indicated time points p.i.. 
(C) HeLa wt cells were incubated with the pan-caspase inhibitor zVAD (20 µM) and the calpain 
inhibitor ALLN (1 nM). After 1 h pre-incubation, cells were infected with S. flexneri (S.f.) (MOI30). 
Cytosolic fractions were analysed by Western blotting at the indicated time points p.i.. 
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Upon proteolytic processing by caspase-8, the C-terminal fragment of BID rapidly 
accumulates at the mitochondria and initiates mitochondrial outer membrane 
permeabilisation leading to apoptotic cell death (Billen et al., 2008). In order to explore the 
potency of the two different BID fragments to release mitochondrial SMAC, the caspase-8 or 
calpain-cleaved BID fragments were ectopically expressed in HeLa cells. Both BID fragments 
promoted the release of similar amounts of SMAC (Figure 18). Strikingly, overexpression of 
caspase-8-cleaved BID (BIDcasp8) induced Cyt c release whereas cytosolic Cyt c was barely 
detectable upon overexpression of calpain-cleaved BID (BIDcalp). Accordingly, only caspase-
8-cleaved BID potently induced caspase-9 activation. 
In conclusion, these data indicate that S. flexneri infection induces calpain-dependent BID 
activation and identifies calpain-cleaved BID as a mediator of mitochondrial SMAC release, 
but not of Cyt c. 
 
 
F igure 18. SMAC is select ively re leased upon ectopic expression of BIDcalp.  
HeLa wt cells were transiently transfected with the indicated concentrations of expression vectors 
encoding GFP-BIDcasp8, GFP-BIDcalp or empty GFP-vector. Mitochondria and cytosolic extracts were 
analysed by Western blotting. 
 
 
XIAP confers immunity against S. f lexneri infection in vivo 
To investigate the physiological relevance of XIAP during anti-bacterial inflammatory 
responses, we employed a previously established infection model, in which intravenousely 
injected S. flexneri colonise the liver of infected mice and induce the formation of 
microgranuloma-like lesions (Martino et al., 2005). To demonstrate that extracelluar bacterial 
components of S. flexneri are not sufficient to induce liver damage, we first showed that only 
the invasive strain of S. flexneri M90T and not the isogenic non-invasive control strain BS176 
induced necrotic liver lesions associated with increased mortality upon infection in wildtype 
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animals at doses beyond 1x108 colony forming units (cfu) (Figure 19A). Infection of XIAP 
knockout mice (XIAP-/-) with S. flexneri M90T (1x107 cfu) revealed a significant difference in 
sensitivity to infection compared to wildtype mice (Figure 19B). To further investigate the 
increased susceptibility of XIAP knockout mice to S. flexneri infection, we analysed the livers 
of infected XIAP knockout and wild type mice. Macroscopic as well as histological 
examinations revealed striking differences in their capacity to contain the inflammatory 
response to S. flexneri infection (Figure 19C and 19D). Whereas wildtype livers showed 
discrete granuloma-like areas of necrosis, enclosed and contained by a small rim of 
mononuclear cell aggregates, the livers of XIAP knockout mice showed disseminated 
necrotic lesions and broadly scattered inflammatory cells throughout the liver tissue 
(Figure 19D). These data reveal for the first time that XIAP knockout mice are profoundly 
impaired in their capacity to mount a directed inflammatory response to contain S. flexneri 
and as a result succumb to overwhelming bacterial infection.  
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Figure 19. XIAP-/- and XIAPliver-/- mice are more susceptib le to infect ion with S. f lexner i . 
(A) Wild type mice were i.v. infected with invasive S. flexneri M90T or non-invasive S. flexneri BS176 
with the indicated cfu. Survival was monitored for 48 h. (n=5 in each group, *p<0.05) 
(B) Kaplan-Meier curve of wild type (wt) and XIAP-/- mice infected with S. flexneri M90T (1x107 cfu). 
(XIAP-/-: n=9; wt: n=9) 
(C) Wild type mice and XIAP-/- mice were treated as in (B). Mice were sacrificed after 48 h and 
representative livers were analysed macroscopically with a SC 100 digital colour camera. 
(D) Histological analysis of mouse liver at 48 h p.i.. Sections of infected liver were stained with 
hematoxylin and eosin or the indicated antibody, respectively. 
(E) XIAPfl/fl and XIAPliver-/- mice were infected with S. flexneri M90T (1x107 cfu) as in (B). Mice were 
sacrificed after 24 h and livers were analysed macroscopically as in (C).  
 
 
The systemic infection of mice with S. flexneri may not only lead to the bacterial colonisation 
of different organs and tissues but may similarly colonise immune cells and might affect the 
susceptibility towards S. flexneri. In order to specifically examine the role of XIAP in infected 
hepatocytes, a liver-specific XIAP knockout mouse was established. Liver-specific XIAP 
knockout mice (XIAPliver-/-) and the corresponding wildtype mice (XIAPfl/fl) were infected with 
S. flexneri M90T (1x107 cfu). Along with the XIAP complete-knockout data, the number and 
size of the necrotic liver lesions were much more severe in the liver specific 
XIAPliver-/- knockout mice than in the corresponding wildtype mice (XIAPfl/fl) (Figure 19E). 
Interestingly, liver-specific XIAP deficiency did not culminate in increased mortality upon 
S. flexneri infection, suggesting that an overwhelming dysfunction of further tissues underlie 
the observed sensitivity of XIAP deficient mice to S. flexneri (data not shown). Nevertheless, 
these observations support the idea that XIAP is necessary for the cellular inflammatory 
signalling in response to S. flexneri infection, which in turn promotes an immune response to 
clear S. flexneri infection.  
Finally, our in vitro analyses demonstrated that XIAP-mediated immune signalling is efficiently 
antagonised by the BID-mediated release of SMAC. Accordingly, in SMAC-/-/OMI+/- knockout 
mice, XIAP-mediated inflammation should be unopposed and therefore mice should be more 
potent in clearing S. flexneri infection. Indeed, SMAC-/-/OMI+/- knockout mice survived 
S. flexneri infection for a significantly longer period compared to wild type animals 
(Figure 20A, upper panel). Congruently, the livers of infected SMAC-/-/OMI+/- knockout mice 
revealed fewer necrotic lesions than the corresponding wild type mice (Figure 20A lower 
panel), suggesting an efficient elimination of bacteria by non-antagonised XIAP-mediated 
immune signalling. Furthermore, BID knockout mice should similarly be unable to oppose 
XIAP-mediated inflammatory response against S. flexneri based on the lack of SMAC 
release. Indeed, unlike the corresponding wild type mice, BID knockout mice (BID-/-) 
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appeared to be resistant to S. flexneri–induced infection (Figure 20B, upper panel) and 
develop fewer necrotic liver lesions compared to the corresponding wild type mice 
(Figure 20B, lower panel). Overall, these data underscore the pivotal role of XIAP in 
orchestrating the immune inflammatory response against S. flexneri. 
 
 
F igure 20. SMAC-/-/OMI+/- and BID-/- mice show prolonged survival upon infect ion with 
S.f lexner i .  
(A) Kaplan Meier curve of wild type (wt) and SMAC-/-/OMI+/- mice infected with S. flexneri M90T (1x108) 
(upper panel) and macroscopic analysis of the liver (lower panel). (SMAC-/-/OMI+/-: n=11; wt: n=9) 
(B) Kaplan Meier curve of wild type (wt) and BID-/- mice infected with S. flexneri M90T (1x108) (upper 
panel) and macroscopic analysis of the liver (lower panel). (BID-/-: n=9; wt: n=10) 
 
In conclusion, these results demonstrate that BID-mediated SMAC-release facilitates the 
antagonisation of XIAP to escape the host immune response towards S. flexneri. 
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Discussion 
In this work we describe a novel strategy of Shigella bacteria to evade the host cell immune 
response. We show that S. flexneri induces the calpain-mediated activation of BID, which 
triggers the BAX/BAK independent and selective release of SMAC and OMI from the 
mitochondrial inter-membrane space into the cytoplasm to antagonise the inflammatory 
mediator XIAP. In contrast to apoptotic stimuli, S. flexneri-induced mitochondrial membrane 
permeabilisation does not deplete the mitochondrial membrane potential, permitting Cyt c to 
be retained inside the mitochondria thus avoiding apoptotic cell death. This novel strategy 
ensures the host cell’s survival and supports bacterial propagation. 
 
XIAP is essential for the immune response against intracel lular 
S. f lexneri 
Following infection of the intestinal epithelium by S. flexneri, an inflammatory response is 
initiated that involves intracellular sensing of bacterial peptidoglycans by NOD1, leading to 
activation of NF-κB and the release of inflammatory chemokines such as IL-8, that promote 
the infiltration of the mucosa with immune cells (Phalipon and Sansonetti, 2007). Recently, 
XIAP was identified as an essential component of the NOD signalling cascade (Krieg et al., 
2009; Damgaard et al., 2012). However, the use of minimal peptidoglycan fragments to 
stimulate intracellular NOD signalling in these studies cannot fully reflect the complexity of 
bacterial infection. 
Our study for the first time implicates XIAP in NOD1-mediated NF-κB signalling after infection 
with S. flexneri in both, cultured epithelial cells (Figure 6B and 7A) and in mouse models 
(Figure 19). Whole-body XIAP knockout mice showed significantly reduced survival in 
response to S. flexneri compared to wild type littermates and developed extensive liver 
damage characterised by severe necrotic lesions (Figure 19C). Previous studies have shown 
that XIAP knockout mice challenged with another Gram-negative bacterium 
L. monocytogenes also showed a drastically decreased survival rate due to a greater 
bacterial burden in the liver and reduced levels of inflammatory cytokines in bone marrow 
derived macrophages (Bauler et al., 2008). These authors proposed that XIAP played a 
critical role in modulating NF-κB activation and cytokine response in infected macrophages 
as effector cells of the innate immune response. They further show that the loss of 
inflammatory cytokine production in XIAP-deficient macrophages is thought to permit 
uncontrolled bacterial propagation in spleen and liver. However, our own data in vitro 
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showed that NF-κB activation was abolished in S. flexneri-infected epithelial cells when XIAP 
was down-regulated in HeLa cells or knocked-out in MEFs from XIAP deficient mice, 
suggesting that cell autonomous XIAP functions of epithelial cells could also be involved in 
the observed phenotype after S. flexneri infection. To investigate whether the liver damage 
observed in whole-body XIAP knock out mice could be due to the cell autonomous loss of 
XIAP function in the hepatocytes regardless of its functions in immune cells, we generated a 
novel hepatocyte-specific XIAP knockout mouse model. Remarkably, S. flexneri infection in 
this model reproduced the liver lesions observed in the whole-body XIAP knockout mice 
(Figure 19E). These findings highlight the pivotal cell autonomous function played by XIAP in 
epithelial cells during the inflammatory response towards S. flexneri. However, in view of the 
survival benefit of the hepatocyte-specific XIAP knockouts compared with whole-body 
knockout mice in response to S. flexneri infection (data not shown), it is evident that both, the 
cell autonomous functions of XIAP as well as its functions in innate immune cells are required 
for adequate antibacterial protection. Additional analyses of the cytokine production as well 
as the bacterial burden in the liver should substantiate our findings that XIAP is an important 
mediator of inflammation after S. flexneri infection in mice.  
Other members of the IAP family, namely cIAP1 and cIAP2 have also been implicated in 
NOD signalling in response to bacterial infection and cIAP1 as well as cIAP2 deficient mice 
challenged with the NOD agonist MDP reportedly showed a diminished inflammatory 
response (Bertrand et al., 2009). However, in our preliminary analyses of cIAP1 and cIAP2 
deficient MEFs we found no evidence that NF-κB activation was compromised in response 
to S. flexneri infection. cIAP1 and cIAP2 differ from XIAP with regard to their molecular 
functions and others have reported that they are not essential for NOD signalling (Damgaard 
et al., 2012). Given that the precise contribution of cIAP1 and cIAP2 in NOD signalling 
remains unclear in this study, we focussed on the function of XIAP in NOD signalling.  
In order to investigate the role of XIAP in S. flexneri infection in vivo, it was important to 
establish an appropriate mouse model of infection. Unlike in humans, oral infection of adult 
mice with S. flexneri does not induce Shigellosis (Phalipon and Sansonetti, 2007). The 
reasons for this resistance remain unknown, however, new-born mice (4 days old) are 
susceptible to infection, which led Fernandez et al., 2003 to develop an oral new-born 
mouse infection model. Unfortunately, the new-born mouse model is extremely sensitive to 
age since 5-day-old new-borns are already refractory to infection. In this study, we therefore 
decided to use the intravenous infection mouse model that was initially described by Martino 
et al., 2005. In this model, injection of S. flexneri into the tail vein of recipient mice leads to 
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immediate micro-granuloma formation, augmented production of cytokine mRNA in the liver 
and in the blood and extensive hepatocyte necrosis (Martino et al., 2005). This is an 
important aspect, since Shigellosis in humans is also associated with cytokine production in 
the liver as well as abnormal liver function (Levine et al., 1974). A further advantage of the 
intravenous infection model is that administration of a relatively small number of bacteria is 
sufficient to induce severe inflammation in mice.  
 
SMAC and OMI are selectively released from mitochondria 
Numerous studies focussing on mitochondrial outer membrane permeabilisation have 
contributed to the current dogma that in apoptotic cells the release of mitochondrial proteins 
including SMAC, OMI and Cyt c from the inter membrane space (IMS) into the cytosol is a 
simultaneous process (Munoz-Pinedo et al., 2006; Youle and Strasser, 2008). In contrast, 
our data show that following S. flexneri infection, the selective release of soluble IMS proteins 
such as SMAC and OMI can be uncoupled from the simultaneous release of Cyt c 
(Figure 12A). This observation gives rise to further questions regarding the nature of the 
selective release mechanism. The current view holds that all IMS proteins are released 
through the same mitochondrial pore, which is formed by BAX and BAK molecules, even 
though the nature and compositions of this pore is still under investigation. BAX activation 
has been viewed as an immediate early event preceding mitochondrial outer membrane 
permeabilisation in apoptotic cells (Kashkar et al., 2005). In striking contrast to apoptotic 
stimuli, the release of SMAC and OMI in S. flexneri-infected cells was not accompanied by 
BAX activation (Figure 12A), indicating that S. flexneri induces mitochondrial outer membrane 
permeabilisation in a non-apoptotic manner. The selective release of SMAC and OMI 
therefore implies the existence of release mechanisms that are separate from the BAX/BAK 
pore. That such BAX/BAK independent release mechanisms in principle exist, is illustrated 
for example by the mitochondrial permeability transition pore that resides at contact sites 
between the mitochondrial outer and inner membranes and facilitates the release of IMS 
proteins from the mitochondria after Ca2+ accumulation (Henry-Mowatt et al., 2004). 
However, this event leads to complete rupture of the mitochondria, which is clearly different 
from the situation observed upon S. flexneri infection, where the mitochondria remain intact 
(Figure 13). Regarding the nature and selectivity of the putative BAX/BAK-independent 
release mechanism, our findings suggest that it does not simply operate by size exclusion 
since SMAC (21 kDa) and OMI (36 kDa) are both larger than Cyt c (14 kDa). An alternative 
possibility to consider is that Cyt c is in fact released into the cytoplasm along with SMAC 
and OMI but is subject to rapid proteasomal degradation explaining why apoptosis is 
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avoided as well as why Cyt c cannot be detected in cytosolic fractions. If this were the case, 
the level of Cyt c inside the mitochondria should decrease during the course of infection. 
However, we can discount this possibility based on our observation that i) Cyt c levels in 
isolated mitochondria remain unchanged during infection (Figure 12C) ii) immunofluorescent 
detection of Cyt c shows a mitochondrial rather than a diffuse cytoplasmic distribution 
(Figure 12B) iii) inhibition of the proteasome using bortezomib does not lead to Cyt c 
accumulation in the cytosolic fraction (data not shown).   
 
Calpain-cleaved BID induces the selective release of SMAC  
BID has been described as a pro-apoptotic protein that is activated upon caspase-8 
cleavage (Li et al., 1998; Luo et al., 1998). The C-terminal BID cleavage product translocates 
to the mitochondria where it leads to mitochondrial membrane permeabilisation through the 
formation of the BAX/BAK pore that facilitates the simultaneous release of SMAC, OMI and 
Cyt c into the cytosol, culminating in apoptotic cell death. Several other proteases have also 
been shown to potently cleave BID, including calpain (Billen et al., 2008) - a Ca2+-dependent 
cysteine protease, known for its function in cytoskeletal remodelling.  
Intriguingly, we and others have shown that S. flexneri infection leads to activation of calpain 
(Bergounioux et al., 2012, Figure 17A). Importantly, our findings not only demonstrate that 
S. flexneri infection results in calpain-mediated BID cleavage (Figure 17B) – but that unlike 
caspase-8-cleaved BID, calpain-cleaved BID preferentially induces the release of SMAC but 
not of Cyt c from the mitochondria (Figure 18). Accordingly, calpain-cleaved BID differs from 
caspase-8-cleaved BID in its ability to selectively release SMAC without releasing Cyt c from 
the mitochondria, thus preventing apoptotic cell death. It has been shown previously, that 
caspase-8-cleaved recombinant BID activates BAX and triggers apoptotic cell death by 
inducing ultrastructural changes in the mitochondria including disruption of cristae junctions 
and opening of the cristae, where the majority of Cyt c is localised (Scorrano et al., 2002; 
D’Herde et al., 2000). The structural changes of the mitochondria at the onset of apoptosis 
are induced by the depletion of the mitochondrial membrane potential (ΔΨm) and are 
required for the efficient release of Cyt c into the cytosol (Gottlieb et al., 2003). Accordingly, 
Cyt c release in response to apoptotic stimulation can be avoided, given that the ΔΨm is 
maintained for example by stimulating the respiratory chain with succinate (Gottlieb et al., 
2003). Our data show, that in contrast to apoptotic stimuli, infection with S. flexneri does not 
involve the activation of BAX (Figure 12A) and the integrity of the mitochondrial structure as 
well as the ΔΨm is maintained (Figure 13). Therefore, after S. flexneri infection the calpain-
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cleaved BID fragment, does not induce collateral mitochondrial damage and therefore 
favours the retention of Cyt c inside the mitochondria, permitting infected cells to escape cell 
death and allow bacterial propagation; while SMAC/OMI are selectively released from the 
mitochondria to oppose the XIAP-mediated inflammatory response. 
Our observation that calpain-mediated BID cleavage occurs after S. flexneri infection is 
supported by at least one previous report where calpain-mediated BID cleavage is described 
in the context of ischemic reperfusion (Chen et al., 2001). In contrast to our own 
observations, these authors claimed to observe the release of Cyt c from isolated 
mitochondria. Critically, however, Chen et al. failed to observe caspase activation calling the 
significance of their observed Cyt c release into question. That BID cleavage products can 
induce the selective release of SMAC from the mitochondria is supported by a report by 
Deng and colleagues who showed that activation of JNK following TNF stimulation leads to 
the BID cleavage product jBID, that induces the preferential release of SMAC from the 
mitochondria without inducing apoptosis (Deng et al., 2003), although the underlying 
mechanism and whether Cyt c is involved or not remains unclear. Even though it appears, 
that jBID shares the capacity for selective SMAC release with calpain cleaved BID; the size 
and therefore structural differences of the cleavage products might argue against a common 
mechanism.  
Structural analyses showed that BID is highly similar to BAX or BAK (Suzuki et al., 2000; 
Moldoveanu et al., 2006). It is therefore assumed that after proteolytic activation, BID 
cleavage products are able to insert into the outer mitochondrial membrane in a BAX-like 
manner (Billen et al., 2008). Conceivably, calpain-cleaved BID itself could therefore form a 
pore in the mitochondrial outer membrane to facilitate the selective release of SMAC after 
S. flexneri infection. Given its smaller size compared to caspase-8-cleaved BID, it is possible 
that calpain-cleaved BID could undergo alternative folding and insertion into the 
mitochondrial outer membrane, which does not involve the activation of BAX and is therefore 
less potent to induce apoptosis. In order to investigate this hypothesis further, protein-
membrane interaction studies with recombinant calpain cleaved BID could help to elucidate 
the insertion mechanisms. 
Recently, BID has been implicated in the regulation of cellular pathways other than apoptosis 
including NOD signalling (Yeretssian et al., 2011). Specifically, BID was identified in a 
genome-wide RNA-interference screen as a component of the NOD-signalling cascade 
leading to NF-κB activation and the production of inflammatory cytokines. Accordingly, BID 
knockout mice were unable to mount a cytokine response towards NOD stimulation. This 
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study is controversial, however, since we and others have been unable to confirm the pro-
inflammatory role of BID in NOD-signalling (Nachbur et al., 2012). In fact, our data show that 
BID cleavage after S. flexneri infection has anti-inflammatory functions caused by the 
selective release of SMAC, leading to XIAP inhibition and consequently interrupted NOD-
signalling (Figure 18). In keeping with the proposed anti-inflammatory function of BID, BID 
knockout mice were less sensitive to S. flexneri infection compared to wild type mice, 
resulting in prolonged survival and fewer necrotic liver lesions (Figure 20B).   
 
Therapeutic impl ications  
Anti-virulence drugs targeting host proteins co-opted by bacterial pathogens are emerging 
as a potential alternative in addition to antibiotics, avoiding the intense selection pressure, 
which has led many bacterial strains to become resistant (Baron, 2010).  
In this regard, our finding that S. flexneri employs the selective release of SMAC and OMI to 
interrupt the XIAP mediated anti-bacterial response has potential therapeutic implications. As 
a strategy to restore the pro-inflammatory activity of XIAP and boost the immune response 
towards S. flexneri infection, the XIAP antagonist SMAC represents an attractive therapeutic 
target. Indeed, we showed that when SMAC is down-regulated with specific siRNA in 
epithelial cells or is absent in MEFs derived from SMAC and OMI deficient mice, the 
inflammatory response is enhanced as illustrated by increased NF-κB activity (Figure 10). 
Furthermore we showed that, SMAC-/-/OMI+/- mice were significantly more resistant to 
S. flexneri and developed fewer necrotic liver lesions compared to their wild type littermates 
(Figure 20A). These findings illustrate the critical function of unopposed XIAP activity in 
controlling bacterial infections and highlight SMAC as a promising therapeutic target for anti-
virulence therapy. Although the search for SMAC inhibitors is in an early phase, due to the 
relatively low molecular mass and relatively small interaction surface with XIAP, screens for a 
“small molecule” inhibitor have already been initiated.  
Another attractive therapeutic target identified in our study is calpain. Calpain inhibitors 
already exist and have been successfully used to target other bacterial functions such as 
phagosomal escape of L. monocytogenes thus blocking bacterial propagation (Lopez-
Castejon et al., 2012). In the context of S. flexneri infection, drugs targeting calpain could 
prevent the BID-mediated release of SMAC and OMI in response to bacterial infection and 
therefore restore the XIAP-mediated immune responses to clear intracellular bacteria.  
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Conclusion 
Recent evidence suggests that XIAP, besides its important function in apoptosis, also plays a 
critical role in innate immunity. Importantly, XIAP truncation or deletion in humans is 
associated with X-linked lymphoproliferative syndrome 2 (XLP type 2) a rare primary 
immunodeficiency syndrome associated with colitis (Rigaud et al., 2006; Pachlopnik Schmid 
et al., 2011), illustrating the important role of XIAP in immune regulation and its relevance for 
human inflammatory diseases.  
Here we show that XIAP is also involved in regulating the immune response against bacterial 
infections. Our study sheds light on the intricate mechanisms employed by S. flexneri to 
efficiently down-regulate the host cell immune response towards bacterial infection. We 
demonstrate that S. flexneri hijacks mitochondrial signalling pathways to antagonise the 
inflammatory mediator XIAP by selectively releasing SMAC and OMI from the mitochondrial 
inter membrane space. SMAC and OMI release from mitochondria is dependent on BID, 
which is cleaved by S. flexneri-activated calpain. Unlike caspase-8-cleaved BID, calpain-
cleaved BID does not induce Cyt c release, which in turn ensures host cell survival and thus 
permits bacterial propagation (Figure 21). 
 
F igure 21. Proposed model of bacter ia l  escape from XIAP-mediated immune 
response. Upon cytosolic appearance of S. flexneri, NOD1-signalling involving RIPK2 and XIAP is 
activated and promotes an inflammatory response (activation of NF-κB and IL-8 production) leading 
to bacterial resolution. However, S. flexneri evolved strategies to escape the innate immune defence 
by orchestrating a calpain- and BID-mediated, predominant release of mitochondrial SMAC and OMI 
to neutralise XIAP-mediated inflammatory signalling. PGN, peptidoglycan. 
RIP2 XIAP
IL-8
S. flexneri
Cytosol
Nucleus
SMAC/
OMI
Mitochondrion
NF-κB
NOD1
Inflammation & 
bacterial resolution
PGN
Cell autonomous immune signaling S.flexneri-induced immune modulation
BID
BIDCalp
Calpain
REFERENCES 
                   
 
47 
References 
Ashida, H., Ogawa, M., Kim, M., Suzuki, S., Sanada, T., Punginelli, C., Mimuro, H., and 
Sasakawa, C. (2011). Shigella deploy multiple countermeasures against host innate 
immune responses. Current Opinion in Microbiology 14, 16–23. 
Baron, C. (2010). Antivirulence drugs to target bacterial secretion systems. Current Opinion 
in Microbiology 13, 100–105. 
Bauler, L.D., Duckett, C.S., and O’Riordan, M.X. (2008). XIAP regulates cytosol-specific 
innate immunity to Listeria infection. PLoS Pathogens 4, e1000142. 
Bergounioux, J., Elisee, R., Prunier, A.L., Donnadieu, F., Sperandio, B., Sansonetti, P., and 
Arbibe, L. (2012). Calpain Activation by the Shigella flexneri Effector VirA Regulates Key 
Steps in the Formation and Life of the Bacterium’s Epithelial Niche. Cell Host & Microbe 
11, 240–252. 
Bertrand, M.J., Doiron, K., Labbe, K., Korneluk, R.G., Barker, P.A., and Saleh, M. (2009). 
Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity 
signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30, 789–801. 
Bertrand, M.J., Lippens, S., Staes, A., Gilbert, B., Roelandt, R., De Medts, J., Gevaert, K., 
Declercq, W., and Vandenabeele, P. (2011). cIAP1/2 are direct E3 ligases conjugating 
diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). 
PloS One 6, e22356. 
Billen, L.P., Shamas-Din, A., and Andrews, D.W. (2008). Bid: a Bax-like BH3 protein. 
Oncogene 27, S93–104. 
Birnbaum, M.J., Clem, R.J., and Miller, L.K. (1994). An apoptosis-inhibiting gene from a 
nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. 
Journal of Virology 68, 2521–2528. 
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., 
Kawasaki, A., Fukase, K., Kusumoto, S., et al. (2003). An essential role for NOD1 in host 
recognition of bacterial peptidoglycan containing diaminopimelic acid. Nature 
Immunology 4, 702–707. 
Chen, M., He, H., Zhan, S., Krajewski, S., Reed, J.C., and Gottlieb, R.A. (2001). Bid is 
cleaved by calpain to an active fragment in vitro and during myocardial 
ischemia/reperfusion. The Journal of Biological Chemistry 276, 30724–30728. 
Chipuk, J.E., Moldoveanu, T., Llambi, F., Parsons, M.J., and Green, D.R. (2010). The BCL-2 
family reunion. Molecular Cell 37, 299–310. 
Clem, R.J., and Miller, L.K. (1994). Control of programmed cell death by the baculovirus 
genes p35 and iap. Molecular and Cellular Biology 14, 5212–5222. 
REFERENCES 
                   
 
48 
Clerc, P., and Sansonetti, P.J. (1987). Entry of Shigella flexneri into HeLa cells: evidence for 
directed phagocytosis involving actin polymerization and myosin accumulation. Infection 
and Immunity 55, 2681–2688. 
Cory, S., and Adams, J.M. (2002). The Bcl2 family: regulators of the cellular life-or-death 
switch. Nature Reviews. Cancer 2, 647–656. 
Crook, N.E., Clem, R.J., and Miller, L.K. (1993). An apoptosis-inhibiting baculovirus gene 
with a zinc finger-like motif. Journal of Virology 67, 2168–2174. 
D’Herde, K., De Prest, B., Mussche, S., Schotte, P., Beyaert, R., Coster, R. V, and Roels, F. 
(2000). Ultrastructural localization of cytochrome c in apoptosis demonstrates 
mitochondrial heterogeneity. Cell Death and Differentiation 7, 331–337. 
Damgaard, R.B., Nachbur, U., Yabal, M., Wong, W.W., Fiil, B.K., Kastirr, M., Rieser, E., 
Rickard, J.A., Bankovacki, A., Peschel, C., et al. (2012). The Ubiquitin Ligase XIAP 
Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity. Molecular Cell 
46, 746–758. 
Deng, Y., Ren, X., Yang, L., Lin, Y., and Wu, X. (2003). A JNK-dependent pathway is 
required for TNFalpha-induced apoptosis. Cell 115, 61–70. 
Deveraux, Q.L., and Reed, J.C. (1999). IAP family proteins-suppressors of apoptosis. Genes 
& Development 13, 239–252. 
Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. (1997). X-linked IAP is a 
direct inhibitor of cell-death proteases. Nature 388, 300–304. 
Dewson, G., and Kluck, R.M. (2009). Mechanisms by which Bak and Bax permeabilise 
mitochondria during apoptosis. Journal of Cell Science 122, 2801–2808. 
Dymecki, S.M. (1996). Flp recombinase promotes site-specific DNA recombination in 
embryonic stem cells and transgenic mice. PNAS 93, 6191–6196. 
Eckelman, B.P., and Salvesen, G.S. (2006). The human anti-apoptotic proteins cIAP1 and 
cIAP2 bind but do not inhibit caspases. The Journal of Biological Chemistry 281, 3254–
3260. 
Fernandez, M.I., Thuizat, A., Pedron, T., Neutra, M., Phalipon, A., and Sansonetti, P.J. 
(2003). A newborn mouse model for the study of intestinal pathogenesis of shigellosis. 
Cellular Microbiology 5, 481–491. 
Fuentes-Prior, P., and Salvesen, G.S. (2004). The protein structures that shape caspase 
activity, specificity, activation and inhibition. The Biochemical Journal 384, 201–232. 
Galbán, S., and Duckett, C.S. (2010). XIAP as a ubiquitin ligase in cellular signaling. Cell 
Death and Differentiation 17, 54–60. 
Gesellchen, V., Kuttenkeuler, D., Steckel, M., Pelte, N., and Boutros, M. (2005). An RNA 
interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate 
immune signalling in Drosophila. EMBO Rep 6, 979–984. 
REFERENCES 
                   
 
49 
Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., Bertin, J., 
DiStefano, P.S., Yaniv, M., Sansonetti, P.J., et al. (2001). CARD4/Nod1 mediates NF-
kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2, 736–742. 
Girardin, S.E., Boneca, I.G., Carneiro, L.A., Antignac, A., Jehanno, M., Viala, J., Tedin, K., 
Taha, M.K., Labigne, A., Zahringer, U., et al. (2003). Nod1 detects a unique 
muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584–1587. 
Gottlieb, E., Armour, S.M., Harris, M.H., and Thompson, C.B. (2003). Mitochondrial 
membrane potential regulates matrix configuration and cytochrome c release during 
apoptosis. Cell Death and Differentiation 10, 709–717. 
Gyrd-Hansen, M., and Meier, P. (2010). IAPs: from caspase inhibitors to modulators of NF-
kappaB, inflammation and cancer. Nature Reviews. Cancer 10, 561–574. 
Haubert, D., Gharib, N., Rivero, F., Wiegmann, K., Hösel, M., Krönke, M., and Kashkar, H. 
(2007). PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-
induced actin reorganization. The EMBO Journal 26, 3308–3321. 
Henry-Mowatt, J., Dive, C., Martinou, J.-C., and James, D. (2004). Role of mitochondrial 
membrane permeabilization in apoptosis and cancer. Oncogene 23, 2850–2860. 
Hornig-Do, H.T., Gunther, G., Bust, M., Lehnartz, P., Bosio, A., and Wiesner, R.J. (2009). 
Isolation of functional pure mitochondria by superparamagnetic microbeads. Analytical 
Biochemistry 389, 1–5. 
Jost, P.J., Grabow, S., Gray, D., McKenzie, M.D., Nachbur, U., Huang, D.C.S., Bouillet, P., 
Thomas, H.E., Borner, C., Silke, J., et al. (2009). XIAP discriminates between type I and 
type II FAS-induced apoptosis. Nature 460, 1035–1039. 
Kashkar, H. (2010). X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow 
promise. Clinical Cancer Research 16, 4496–4502. 
Kashkar, H., Wiegmann, K., Yazdanpanah, B., Haubert, D., and Kronke, M. (2005). Acid 
sphingomyelinase is indispensable for UV light-induced Bax conformational change at 
the mitochondrial membrane. The Journal of Biological Chemistry 280, 20804–20813. 
Kashkar, H., Seeger, J.M., Hombach, A., Deggerich, A., Yazdanpanah, B., Utermohlen, O., 
Heimlich, G., Abken, H., and Kronke, M. (2006). XIAP targeting sensitizes Hodgkin 
lymphoma cells for cytolytic T-cell attack. Blood 108, 3434–3440. 
Kashkar, H., Deggerich, A., Seeger, J.M., Yazdanpanah, B., Wiegmann, K., Haubert, D., 
Pongratz, C., and Kronke, M. (2007). NF-kappaB-independent down-regulation of XIAP 
by bortezomib sensitizes HL B cells against cytotoxic drugs. Blood 109, 3982–3988. 
Kaufmann, T., Tai, L., Ekert, P.G., Huang, D.C.S., Norris, F., Lindemann, R.K., Johnstone, 
R.W., Dixit, V.M., and Strasser, A. (2007). The BH3-only protein bid is dispensable for 
DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129, 
423–433. 
REFERENCES 
                   
 
50 
Kaufmann, T., Strasser, a, and Jost, P.J. (2012). Fas death receptor signalling: roles of Bid 
and XIAP. Cell Death and Differentiation 19, 42–50. 
Kellendonk, C., Opherk, C., Anlag, K., Schütz, G., and Tronche, F. (2000). Hepatocyte-
specific expression of Cre recombinase. Genesis 26, 151–153. 
Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon 
with wide-ranging implications in tissue kinetics. British Journal of Cancer 26, 239–257. 
Krieg, A., Correa, R.G., Garrison, J.B., Le Negrate, G., Welsh, K., Huang, Z., Knoefel, W.T., 
and Reed, J.C. (2009). XIAP mediates NOD signaling via interaction with RIP2. PNAS 
106, 14524–14529. 
Kufer, T.A., Banks, D.J., and Philpott, D.J. (2006). Innate immune sensing of microbes by 
Nod proteins. Annals Of The New York Academy Of Sciences 1072, 19–27. 
LaCasse, E.C., Mahoney, D.J., Cheung, H.H., Plenchette, S., Baird, S., and Korneluk, R.G. 
(2008). IAP-targeted therapies for cancer. Oncogene 27, 6252–6275. 
Lamkanfi, M., and Dixit, V.M. (2010). Manipulation of host cell death pathways during 
microbial infections. Cell Host & Microbe 8, 44–54. 
Levine, V., Overturf, G., and Mathies, A. (1974). Shigella dysenteriae type 1--severe 
dysentery and sepsis with hematologic, hepatic and renal complications. West J Med. 
121, 501–504. 
Li, H., Zhu, H., Xu, C.J., and Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the 
mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501. 
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang, X. 
(1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex 
initiates an apoptotic protease cascade. Cell 91, 479–489. 
Lindsten, T., Ross, A.J., King, A., Zong, W.X., Rathmell, J.C., Shiels, H.A., Ulrich, E., 
Waymire, K.G., Mahar, P., Frauwirth, K., et al. (2000). The combined functions of 
proapoptotic Bcl-2 family members bak and bax are essential for normal development 
of multiple tissues. Molecular Cell 6, 1389–1399. 
Lopez-Castejon, G., Corbett, D., Goldrick, M., Roberts, I.S., and Brough, D. (2012). 
Inhibition of calpain blocks the phagosomal escape of Listeria monocytogenes. PloS 
One 7, e35936. 
Lu, M., Lin, S.C., Huang, Y., Kang, Y.J., Rich, R., Lo, Y.C., Myszka, D., Han, J., and Wu, H. 
(2007). XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 
dimerization. Molecular Cell 26, 689–702. 
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998). Bid, a Bcl2 interacting 
protein, mediates cytochrome c release from mitochondria in response to activation of 
cell surface death receptors. Cell 94, 481–490.
REFERENCES 
                   
 
51 
Mantis, N., Prevost, M.C., and Sansonetti, P. (1996). Analysis of epithelial cell stress 
response during infection by Shigella flexneri. Infection and Immunity 64, 2474–2482. 
Martino, M.C., Rossi, G., Tattoli, I., Martini, I., Chiavolini, D., Cortese, G., Pozzi, G., and 
Bernardini, M.L. (2005). Intravenous infection of virulent shigellae causes fulminant 
hepatitis in mice. Cellular Microbiology 7, 115–127. 
Martinou, J.C., and Youle, R.J. (2006). Which came first, the cytochrome c release or the 
mitochondrial fission? Cell Death and Differentiation 13, 1291–1295. 
Martins, L.M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N.F., Lemoine, N.R., 
Savopoulos, J., Gray, C.W., Creasy, C.L., Dingwall, C., et al. (2002). The serine protease 
Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. The Journal 
of Biological Chemistry 277, 439–444. 
Martins, L.M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., 
Grau, E., Geppert, M., Livi, G.P., et al. (2004). Neuroprotective role of the Reaper-
related serine protease HtrA2/Omi revealed by targeted deletion in mice. Molecular and 
Cellular Biology 24, 9848–9862. 
McKenzie, M.D., Carrington, E.M., Kaufmann, T., Strasser, A., Huang, D.C.S., Kay, T.W.H., 
Allison, J., and Thomas, H.E. (2008). Proapoptotic BH3-only protein Bid is essential for 
death receptor-induced apoptosis of pancreatic beta-cells. Diabetes 57, 1284–1292. 
Mizutani, Y., Nakanishi, H., Li, Y.N., Matsubara, H., Yamamoto, K., Sato, N., Shiraishi, T., 
Nakamura, T., Mikami, K., Okihara, K., et al. (2007). Overexpression of XIAP expression 
in renal cell carcinoma predicts a worse prognosis. International Journal of Oncology 30, 
919–925. 
Moldoveanu, T., Liu, Q., Tocilj, A., Watson, M., Shore, G., and Gehring, K. (2006). The X-ray 
structure of a BAK homodimer reveals an inhibitory zinc binding site. Molecular Cell 24, 
677–688. 
Munoz-Pinedo, C., Guio-Carrion, A., Goldstein, J.C., Fitzgerald, P., Newmeyer, D.D., and 
Green, D.R. (2006). Different mitochondrial intermembrane space proteins are released 
during apoptosis in a manner that is coordinately initiated but can vary in duration. 
PNAS 103, 11573–11578. 
Nachbur, U., Vince, J.E., O’Reilly, L. a, Strasser, A., and Silke, J. (2012). Is BID required for 
NOD signalling? Nature 488, 4–6. 
Pachlopnik Schmid, J., Canioni, D., Moshous, D., Touzot, F., Mahlaoui, N., Hauck, F., 
Kanegane, H., Lopez-Granados, E., Mejstrikova, E., Pellier, I., et al. (2011). Clinical 
similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 
(XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 117, 1522–1529. 
Phalipon, A., and Sansonetti, P.J. (2007). Shigella’s ways of manipulating the host intestinal 
innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 85, 119–
129. 
REFERENCES 
                   
 
52 
Philpott, D.J., Yamaoka, S., Israel, A., and Sansonetti, P.J. (2000). Invasive Shigella flexneri 
activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular 
response and leads to IL-8 expression in epithelial cells. Journal of Immunology 165, 
903–914. 
Prakash, H., Albrecht, M., Becker, D., Kuhlmann, T., and Rudel, T. (2010). Deficiency of XIAP 
leads to sensitization for Chlamydophila pneumoniae pulmonary infection and 
dysregulation of innate immune response in mice. The Journal of Biological Chemistry 
285, 20291–20302. 
Rigaud, S., Fondaneche, M.C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., 
Le Deist, F., Rieux-Laucat, F., Revy, P., et al. (2006). XIAP deficiency in humans causes 
an X-linked lymphoproliferative syndrome. Nature 444, 110–114. 
Salvesen, G.S., and Duckett, C.S. (2002). IAP proteins: blocking the road to death’s door. 
Nature Reviews. Molecular Cell Biology 3, 401–410. 
Sattler, M., Liang, H., Nettesheim, D., Meadows, R.P., Harlan, J.E., Eberstadt, M., Yoon, 
H.S., Shuker, S.B., Chang, B.S., Minn, A.J., et al. (1997). Structure of Bcl-xL-Bak 
peptide complex: recognition between regulators of apoptosis. Science 275, 983–986. 
Schimmer, A.D., Dalili, S., Batey, R.A., and Riedl, S.J. (2006). Targeting XIAP for the 
treatment of malignancy. Cell Death and Differentiation 13, 179–188. 
Scorrano, L., Ashiya, M., Buttle, K., Weiler, S., Oakes, S.A., Mannella, C.A., and Korsmeyer, 
S.J. (2002). A distinct pathway remodels mitochondrial cristae and mobilizes 
cytochrome c during apoptosis. Developmental Cell 2, 55–67. 
Seeger, J.M., Brinkmann, K., Yazdanpanah, B., Haubert, D., Pongratz, C., Coutelle, O., 
Kronke, M., and Kashkar, H. (2010). Elevated XIAP expression alone does not confer 
chemoresistance. British Journal of Cancer 102, 1717–1723. 
Strasser, A., O’Connor, L., and Dixit, V.M. (2000). Apoptosis signaling. Annual Review of 
Biochemistry 69, 217–245. 
Suzuki, M., Youle, R.J., and Tjandra, N. (2000). Structure of Bax: coregulation of dimer 
formation and intracellular localization. Cell 103, 645–654. 
Tait, S.W., and Green, D.R. (2010). Mitochondria and cell death: outer membrane 
permeabilization and beyond. Nature Reviews. Molecular Cell Biology 11, 621–632. 
Tamm, I., Richter, S., Oltersdorf, D., Creutzig, U., Harbott, J., Scholz, F., Karawajew, L., 
Ludwig, W.-D., and Wuchter, C. (2004a). High expression levels of x-linked inhibitor of 
apoptosis protein and survivin correlate with poor overall survival in childhood de novo 
acute myeloid leukemia. Clinical Cancer Research 10, 3737–3744. 
Tamm, I., Richter, S., Scholz, F., Schmelz, K., Oltersdorf, D., Karawajew, L., Schoch, C., 
Haferlach, T., Ludwig, W.D., and Wuchter, C. (2004b). XIAP expression correlates with 
monocytic differentiation in adult de novo AML: impact on prognosis. The Hematology 
Journal 5, 489–495. 
REFERENCES 
                   
 
53 
Vandenabeele, P., and Bertrand, M.J. (2012). The role of the IAP E3 ubiquitin ligases in 
regulating pattern-recognition receptor signalling. Nature Reviews. Immunology. 
Vaux, D.L., and Silke, J. (2005). IAPs, RINGs and ubiquitylation. Nature Reviews. Molecular 
Cell Biology 6, 287–297. 
Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E., Moritz, R.L., 
Simpson, R.J., and Vaux, D.L. (2000). Identification of DIABLO, a mammalian protein 
that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43–53. 
Willis, S.N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J.I., Adams, J.M., and Huang, 
D.C. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until 
displaced by BH3-only proteins. Genes & Development 19, 1294–1305. 
Yeretssian, G., Correa, R.G., Doiron, K., Fitzgerald, P., Dillon, C.P., Green, D.R., Reed, J.C., 
and Saleh, M. (2011). Non-apoptotic role of BID in inflammation and innate immunity. 
Nature 474, 96–99. 
Yin, X., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A., and Korsmeyer, S.J. 
(1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 
400, 2–7. 
Youle, R.J., and Strasser, A. (2008). The BCL-2 protein family: opposing activities that 
mediate cell death. Nature Reviews. Molecular Cell Biology 9, 47–59. 
Zou, H., Li, Y., Liu, X., and Wang, X. (1999). An APAF-1.cytochrome c multimeric complex is 
a functional apoptosome that activates procaspase-9. The Journal of Biological 
Chemistry 274, 11549–11556.  
  
APPENDIX 
                   
 
54 
Appendix 
Human BID sequence 
5’-atggactgtgaggtcaacaacggttccagcctcagggatgagtgcatcacaaacctactggtgtttggcttcctccaaagctgttctgac 
aacagcttccgcagagagctggacgcactgggccacgagctgccagtgctggctccccagtgggagggctacgatgagctgcagactg
atggcaaccgcagcagccactcccgcttgggaagaatagaggcagattctgaaagtcaagaagacatcatccggaatattgccaggcac
ctcgcccaggtcggggacagcatggaccgtagcatccctccgggcctggtgaacggcctggccctgcagctcaggaacaccagccgg
tcggaggaggaccggaacagggacctggccactgccctggagcagctgctgcaggcctaccctagagacatggagaaggagaagac
catgctggtgctggccctgctgctggccaagaaggtggccagtcacacgccgtccttgctccgtgatgtctttcacacaacagtgaattttatt
aaccagaacctacgcacctacgtgaggagcttagccagaaatgggatggactga-3’ 
 
Vector map 
 
Casp 8 Calpain 
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